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A B S T R A C T
Background
Stroke patients conventionally receive a substantial part of their rehabilitation in hospital. Services have now been developed which
offer patients in hospital an early discharge with rehabilitation at home (early supported discharge (ESD)).
Objectives
To establish the effects and costs of ESD services compared with conventional services.
Search methods
We searched the trials registers of the Cochrane Stroke Group (January 2012) and the Cochrane Effective Practice and Organisation
of Care (EPOC) Group, MEDLINE (2008 to 7 February 2012), EMBASE (2008 to 7 February 2012) and CINAHL (1982 to 7
February 2012). In an effort to identify further published, unpublished and ongoing trials we searched 17 trial registers (February
2012), performed citation tracking of included studies, checked reference lists of relevant articles and contacted trialists.
Selection criteria
Randomised controlled trials recruiting stroke patients in hospital to receive either conventional care or any service intervention which
has provided rehabilitation and support in a community setting with an aim of reducing the duration of hospital care.
Data collection and analysis
The primary patient outcome was the composite end-point of death or long-term dependency recorded at the end of scheduled follow-
up. Two review authors scrutinised trials and categorised them on their eligibility. We then sought standardised individual patient data
from the primary trialists. We analysed the results for all trials and for subgroups of patients and services, in particular whether the
intervention was provided by a co-ordinated multidisciplinary team (co-ordinated ESD team) or not.
Main results
Outcome data are currently available for 14 trials (1957 patients). Patients tended to be a selected elderly group with moderate disability.
The ESD group showed significant reductions (P < 0.0001) in the length of hospital stay equivalent to approximately seven days.
Overall, the odds ratios (OR) (95% confidence interval (CI)) for death, death or institutionalisation, death or dependency at the end
of scheduled follow-up were OR 0.91 (95% CI 0.67 to 1.25, P = 0.58), OR 0.78 (95% CI 0.61 to 1.00, P = 0.05) and OR 0.80
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(95% CI 0.67 to 0.97, P = 0.02) respectively. The greatest benefits were seen in the trials evaluating a co-ordinated ESD team and
in stroke patients with mild to moderate disability. Improvements were also seen in patients’ extended activities of daily living scores
(standardised mean difference 0.12, 95% CI 0.00 to 0.25, P = 0.05) and satisfaction with services (OR 1.60, 95% CI 1.08 to 2.38, P
= 0.02) but no statistically significant differences were seen in carers’ subjective health status, mood or satisfaction with services. The
apparent benefits were no longer statistically significant at five-year follow-up.
Authors’ conclusions
Appropriately resourced ESD services provided for a selected group of stroke patients can reduce long-term dependency and admission
to institutional care as well as reducing the length of hospital stay. We observed no adverse impact on the mood or subjective health
status of patients or carers.
P L A I N L A N G U A G E S U M M A R Y
Services for reducing duration of hospital care for acute stroke patients
Early supported discharge services aim to allow patients to return home from hospital earlier than usual and receive more rehabilitation
in the familiar environment of their own home. Early supported discharge services are provided by teams of therapists, nurses and
doctors. This review, which identified 14 trials with 1957 participants, found that patients who received these services returned home
earlier and were more likely to remain at home in the long term and to regain independence in daily activities. The best results were
seen with well organised discharge teams and patients with less severe strokes.
B A C K G R O U N D
Description of the condition
Stroke is a global healthcare problem and in most countries is
one of the leading causes of death and acquired adult disability
(Warlow 2008). Stroke is also expensive and consumes 5% of all
health service resources within the UK National Health Service
(Saka 2009). Despite major advances in the medical management
of stroke, the majority of patients continue to rely on post-stroke
rehabilitation interventions (Langhorne 2011). Conventionally,
rehabilitation after stroke is provided in hospital. Thus in-patient
care of disabled stroke patients accounts formuch of the substantial
economic costs (Warlow 2008).
Rehabiliation in hospital can achieve good clinical outcomes. A
recent systematic review evaluating in-patient stroke care has indi-
cated that organised in-patient (stroke unit) care is effective in re-
ducing death and disability (SUTC 2007).However,many impor-
tant questions about stroke service provision remain unanswered.
In particular, are there effective alternatives to in-patient care and
how can care be best provided after discharge from hospital?
Description of the intervention
A previous review (Langhorne 1999) focused on those systems
of care which have been set up as complete alternatives to in-
patient care, i.e. services such as ’hospital at home’, which aim
to prevent stroke patients being admitted to hospital. A second
approach has been to develop services which may accelerate the
discharge of patients already admitted to hospital. These services
have variously been termed ’early supported discharge schemes’,
’early home supported discharge services’, ’accelerated discharge
schemes’ and ’post-discharge support services’, and form the basis
of this review. This review focuses on the effectiveness of such early
supported discharge services.
O B J E C T I V E S
We addressed the following questions of services which offered
stroke patients in hospital an alternative to conventional systems
of care through a policy of early discharge from hospital with
community-based rehabilitation (early supported discharge).
1. Can these alternative services accelerate the return home of
stroke patients who are admitted to hospital?
2. Can such care produce equivalent or better patient and
carer outcomes than conventional care?
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3. Which approaches are most satisfactory to patients and
carers?
4. What are the resource implications of such services?
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised trials that compared conventional
hospital care and discharge procedures with alternative services
which aimed to accelerate the patient’s discharge from hospital.
Therefore, randomisationwill have takenplace relatively early after
hospital admission and before discharge.
Types of participants
Any patient who has been admitted to hospital with a clinical
diagnosis of stroke (defined as an acute focal neurological deficit
caused by cerebrovascular disease). Where possible, we tried to
record stroke severity (level of disability) at randomisation using
activities of daily living (ADL) status.
Types of interventions
We included trials evaluating any intervention that aimed to accel-
erate discharge from hospital with the provision of support (with
or without a ’therapeutic’ rehabilitation intervention) in a commu-
nity setting (early supported discharge). We recorded the specific
type of intervention but this was not used as an exclusion criterion.
We aimed to include trials that focused largely or entirely on stroke
patients. Prespecified subgroups were derived from recognised in-
dicators of in-patient stroke service quality, in particular whether
care was planned and provided by a specialist team whose work
was co-ordinated through regular multidisciplinary meetings.
Types of outcome measures
Primary outcomes
The primary patient outcome was the composite end-point of
death or long-term dependency recorded at the end of scheduled
follow-up. The main focus of the individual patient data analysis
was therefore on the patient outcomes of:
1. death;
2. physical dependency (i.e. dependent on help for transfers,
mobility, washing, dressing or toileting); and
3. place of residence.
The primary resource outcomewas the length of the index hospital
stay. We planned to record other resource outcomes (i.e. readmis-
sion to hospital, number of readmissions, number of readmission
days, cost of in-patient stay, total cost of service interventions) but
in the end were limited to length of the index hospital stay, read-
mission to hospital, and total cost of service interventions.
Secondary outcomes
Secondary outcomes (recorded at the end of scheduled follow-up)
included the following:
1. activities of daily living (ADL) score;
2. extended ADL score;
3. subjective health status;
4. mood (mood or depression score);
5. carer outcomes (carer mood and subjective health status);
6. patient and carer satisfaction and/or service preference.
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module.We searched for trials in all languages and arranged trans-
lation of relevant papers published in languages other than En-
glish.
Electronic searches
We searched the trials registers of theCochrane StrokeGroup (Jan-
uary 2012) and the Cochrane Effective Practice and Organisation
ofCare (EPOC)Group (Febraury 2012). In addition, in collabora-
tion with the Cochrane Stroke Group Trials Search Co-ordinator,
we searched MEDLINE (2008 to February 2012) (Appendix 1),
EMBASE (2008 to February 2012) (Appendix 2) and CINAHL
(1982 to February 2012) (Appendix 3). To avoid duplication of
effort we restricted the searches ofMEDLINE and EMBASE from
January 2008 as these databases have already been searched to that
date for all stroke trails and relevant trials added to the Cochrane
Stroke Group Trials Register.
We searched the following registers of ongoing trials using the
keyword ’stroke’ (February 2012):
• ClinicalTrials.gov (http://clinicaltrials.gov/);
• The Australian New Zealand Clinical Trials Registry (
www.anzctr.org.au);
• CenterWatch Clinical Trials Listing Service (
www.centerwatch.com);
• Chinese Clinical Trial Register (www.chictr.org);
• Community Research & Development Information Service
(of the European Union) (cordis.europa.eu/en/home.html);
• Current Controlled Trials metaRegister of Controlled Trialls
(mRCT) - active and archived registers (www.controlled-
trials.com/mrct) and International Standard Randomised
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Controlled Trial Number Register (www.controlled-trials.com/
isrctn/);
• WHO International Clinical Trials Registry (www.who.int/
trialsearch);
• Hong Kong clinical trials register (
www.hkclinicaltrials.com);
• Clinical Trials Registry - India (CTRI) (www.ctri.in);
• Nederlands Trialregister (www.trialregister.nl/trialreg/
index.asp);
• South African National Clinical Trial Regster (
www.sanctr.gov.za);
• UK Clinical Research Network Portfolio database (
portal.nihr.ac.uk/Pages/Portfolio.aspx);
• UK Clinical Trials Gateway (www.controlled-trials.com/
ukctr);
• UK National Research Regsiter (NRR) (trials and other
research - archived September 2007) (portal.nihr.ac.uk/Pages/
NRRArchive.aspx);
• University Hospital Medical Information Network (UMIN)
Clinical Trials Registry (for Japan) (www.umin.ac.jp/ctr/);
• The Internet Stroke Center - Stroke Trials Registry (
www.strokecenter.org/trials);
• Clinical Trials Results register (www.clinicaltrialresults.org).
Searching other resources
In an effort to identify further published, unpublished and ongo-
ing trials we:
1. performed citation tracking using Web of Science Cited
Reference Search for all included studies;
2. searched the reference lists of included trials and all relevant
articles;
3. obtained further information from individual trialists.
Data collection and analysis
Selection of studies
One review author (PF) read the titles and abstracts of the records
obtained from the electronic searches and excluded obviously ir-
relevant studies. We obtained the full copy of the remaining stud-
ies and two review authors (PF, PL) independently selected studies
for inclusion based on the following eligibility criteria:
1. randomised controlled trial;
2. service intervention providing rehabilitation or physical
support, or both, in a community setting;
3. service aim is to accelerate discharge home from hospital
(i.e. randomisation takes place during hospital admission);
4. trial of stroke patients.
We then contacted the trialists and invited them to join an indi-
vidual patient data review of all comparable trials.
Data extraction and management
Our primary aim was to obtain individual patient data from the
trialists. We contacted the co-ordinators of the eligible trials and
invited them to join a collaborative group. We asked them to pro-
vide a detailed description of their intervention and control ser-
vices and also to provide basic individual patient data particularly
concerning the primary patient outcomes and pre-planned sub-
group analyses. Where these were not available in an appropri-
ate format we sought standardised (tabular) outcome data. Where
data had to be taken from published sources, two review authors
(PF, PL) independently extracted the data using a standard data ex-
traction form. We collected descriptive information about service
characteristics using a standard questionnaire prior to the identi-
fication and analysis of outcome data.
Assessment of risk of bias in included studies
We assessed risk of bias using The Cochrane Collaboration’s risk of
bias tool as described in Chapter 8 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We identified
the method of concealment of treatment allocation, the presence
of an intention-to-treat analysis, and the presence of blinding of
outcome assessment as potentially important factors for sensitivity
analyses, but we did not use them as exclusion criteria.
Measures of treatment effect
The primary patient outcome was the composite end-point of
death or long-term dependency recorded at the end of scheduled
follow-up. Where death, dependency or institutionalisation after
the end of scheduled follow-up were reported, we analysed these
using the odds ratio (OR) and 95% confidence interval (CI).
We sought data on initial stroke severity using the most widely
available marker of functional ability (Activities of Daily Living
(ADL) score during the first week post stroke). Most trials could
easily provide this as the Barthel Index at randomisation. How-
ever, in two trials (Adelaide 2000; London 1999) randomisation
frequently took place later (up to four weeks post stroke). In these
cases, we estimated the initial Barthel assuming a typical recovery
of one Barthel point per week, e.g. Barthel of 14/20 at week four
indicates an initial score of 10/20.
Many secondary outcomes were expressed as continuous outcome
scores. We aimed to analyse these as the mean and standard devia-
tion of the score. Where only medians were available we assumed
these were approximate to the mean. Where only interquartile
ranges (IQR) were reported we inferred the standard deviation as
follows: the IQR will incorporate 50% of the distribution of data
compared with standard deviation which can be expected to in-
clude 70% (+ or - 35%) of the distribution. Therefore, assuming
a normal distribution then one standard deviation should equal
the IQR/(2 x 0.7). Where no other data were provided with the
mean value, we inferred the standard deviation as being at least as
large as the comparable trials using the same measure.
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Unit of analysis issues
Weplanned the analysis on an individual randomised patient level.
However, this update identified one cluster randomised trial. In
view of the modest contribution to the combined analysis we have
not adjusted the analysis for clustering but we have performed a
sensitivity analysis excluding cluster randomised trials.
Dealing with missing data
Where dataweremissing for the primary outcome, we assumed the
patient to be alive, independent and living at home. We explored
the implications of this in a sensitivity analysis.
Assessment of heterogeneity
We planned to determine heterogeneity using the I2 statistic. Sig-
nificant heterogeneity was defined as an I2 of greater than 50%.
Where significant heterogeneity occurred, we explored potential
sources using pre-planned sensitivity analyses.
Assessment of reporting biases
We employed a comprehensive search strategy in an effort to avoid
reporting biases. To identify unpublished studies we searched trial
registers and contacted trialists and other experts in the field.
Data synthesis
We checked all individual patient data for internal consistency and
consistency with published reports. One review author entered
data into the Review Manager software (RevMan 5.1) (RevMan
2011) and a second review author checked the entries.We analysed
binary outcome data using the OR and 95% CI. We used a fixed-
effect model first but replaced this with a random-effects model if
there was significant heterogeneity. If possible, we analysed con-
tinuous outcome data (e.g. ADL scores) using the mean difference
(MD) and 95% CI for identical outcomes and the standard mean
difference (SMD) where different measurement techniques were
used to measure the same outcome domain. We used a fixed-effect
model first but replaced this with a random-effects model if there
was significant heterogeneity. We had to reverse several outcome
scores (e.g. mood scores) to ensure all scores compared were op-
erating in the same direction. This was done by subtracting the
observed score from the maximum possible score.
Subgroup analysis and investigation of heterogeneity
We based pre-planned subgroup analyses on patient characteristics
of age, gender, presence of carer, and stroke severity (Barthel Index
in the first week). We based subgroup analyses of service char-
acteristics on the early supported discharge (ESD) characteristics
(whether based on a co-ordinated multidisciplinary team), ESD
service base (hospital out-reach or community in-reach), and the
nature of the control service (based on a stroke unit or other ser-
vice). We initially trichotomised stroke severity and age but subse-
quently collapsed these into two groups for simplicity and consis-
tency with previous reviews (SUTC 2007).We analysed subgroup
comparisons by deducting the sum of the Chi2 values for each
subgroup from the Chi2 value for the full analysis (where degrees
of freedom = number of subgroups - 1).
Sensitivity analysis
We planned sensitivity analyses around the method of randomisa-
tion (concealment of treatment allocation), an intention-to-treat
analysis, and blinding of outcome assessment.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
(See: Characteristics of ongoing studies; Characteristics of studies
awaiting classification; Characteristics of excluded studies)
Results of the search
The search strategy for previous versions of this review identified
29 potentially eligible trials of which three (from England, New
Zealand and Scotland) were in the early stages of planning but
never started. The original assessors agreed on the inclusion of
10 trials, the exclusion of 14 trials and disagreed on two trials
(Akershus 1998; New York 1986). After discussion and obtaining
more information, both these trials were considered eligible but
one was excluded (New York 1986) as no outcome information
was available (see below). Therefore, the previous version of this
review included 11 trials (ESD trialists 2005).
For this updated review the searches of MEDLINE, EMBASE
and CINAHL identified 1406 records and from these and the
searches of the Cochrane trials registers and other sources, we
identified 13 new potentially eligible trials for consideration using
the four selection criteria (Figure 1). In addition we identified
newly published data for three previously included trials (Montreal
2000; Stockholm 1998; Trondheim 2000).
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Figure 1. Flow diagram illustrating the results of the updated searches
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The assessors agreed on the inclusion of three trials (Copenhagen
2009;Glostrup 2006; Trondheim2004) and the exclusion of three
trials (Grasel 2005; Lincoln 2004; Weiss 2004) (see below), which
were newly identified for this updated review. We require fur-
ther information for two trials (ATTEND pilot trial 2011; Edirne
2001) to assess eligibility, and an additional five trials (Aveiro;
Bergen; Hong Kong; Perth;West Denmark) do not yet have avail-
able outcome data.
Of all 21 excluded studies (Characteristics of excluded studies),
eight recruited a mixed patient group, four examined services to
prevent hospital admission, two were late interventions, two were
non-randomised trials, one recruited patients in a community set-
ting, one (New York 1986) appears eligible but we have been un-
able to identify any outcome data (published or unpublished),
and three studies (Auckland 1999; Ayrshire 2000; Cumbria 2004)
were planned but did not commence recruitment.
We asked the co-ordinators of all eligible trials to provide a detailed
description of their intervention and control services, which was
collected using a standard questionnaire prior to the identification
and analysis of outcome data. We now have descriptive informa-
tion available for all 14 included trials (1957 patients).
Included studies
The services under comparison are outlined in detail (
Characteristics of included studies). We were particularly inter-
ested in establishing the degree of co-ordination and organisation
of the community and hospital services (i.e. whether patients re-
ceived care from a co-ordinated multidisciplinary team with some
specialist interest in stroke which met on a regular basis). By this
definition the following classifications can be made.
Intervention services
1. Early supported discharge (ESD) team co-ordination and
delivery: in nine trials (Adelaide 2000; Belfast 2004; Copenhagen
2009; Glostrup 2006; London 1999; Manchester 2001;
Montreal 2000; Newcastle 1997; Stockholm 1998) the ESD
service comprised a multidisciplinary team which co-ordinated
discharge from hospital, post discharge care and provided
rehabilitation and patient care at home. The multidisciplinary
team met on a regular basis to plan patient care.
2. ESD team co-ordination: in three trials (Oslo 2000;
Trondheim 2000; Trondheim 2004) discharge home and the
immediate post-discharge care was planned and supervised by a
co-ordinated multidisciplinary team. However, care was
subsequently handed over to existing community-based agencies
who provided continuing rehabilitation and support at home.
These community-based agencies did not usually provide co-
ordinated multidisciplinary team care (i.e. input from a
multidisciplinary team which met on a regular basis to plan
patient care).
3. No ESD team: in two trials (Akershus 1998; Bangkok
2002) patients had access to multidisciplinary team care in
hospital but this ended at hospital discharge. Their subsequent
care was provided by a range of community stroke services which
were not planned or provided by a co-ordinated team (Akershus
1998) or were provided by trained healthcare volunteers
(Bangkok 2002).
The boundary between groups (1) and (2) does not appear clear
cut but indicates a spectrum of approaches where an ESD team
plans and co-ordinates discharge, provides early post-discharge re-
habilitation and then hands over care to other community services.
ESD team structure, practices and procedures
Details of ESD team practices can best be obtained from the
original trials. However, we developed a summary description of
the services to indicate the type of service provided. Standard-
ised staffing levels (whole time equivalents (WTE) sufficient to
manage a notional 100 new patients per year) were calculated
from recorded staff contact times (Adelaide 2000; Aveiro;Glostrup
2006; London 1999;Montreal 2000; Newcastle 1997; Stockholm
1998), or a typical team caseload (Belfast 2004; Trondheim 2000;
Trondheim 2004). We assumed staff would have a 35-hour work-
ing week with 20 hours direct contact time and 10 hours indirect
contact time.
Typical ESD teams had approximately 3.0 WTE staff (range 2.5
to 4.6) as follows; medical 0.1, nursing (ranged from 0 to 1.2),
physiotherapy 1.0, occupational therapy 1.0, speech and language
therapy 0.1, assistant 0.2. Variable levels of social work (0 to 0.5
WTE) and secretarial support were also available (Table 1).
The ESD teams could either have a community (community in-
reach) or hospital base (hospital out-reach) with experience in
stroke rehabilitation/neurological rehabilitation (Adelaide 2000;
Belfast 2004; Copenhagen 2009; Glostrup 2006; London 1999;
Manchester 2001; Montreal 2000; Newcastle 1997; Oslo 2000;
Stockholm 1998; Trondheim 2000; Trondheim 2004). All co-or-
dinated their work through regular multidisciplinary team meet-
ings. A typical approach would involve the early identification of
the patient in hospital and a visit from the key worker (case man-
ager) from the ESD team. Discharge was planned with the patient
and carer, often involving a pre-discharge home visit (attended by
the patient) or environmental visit (not attended by the patient).
Team input typically began on the day of discharge and could be
provided as required. In practice this ranged from daily input to
four to five days per week. Typically teams would agree recovery
goals with the patient and negotiate the termination of services
within three months (which would be tapered off as goals were
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achieved). Many teams used a patient-held medical record and
provided a formal discharge summary at the end of input.
Control services
These were categorised on whether organised stroke unit care was
available to patients prior to discharge (Table 1). In nine trials,
all patients (Adelaide 2000; Akershus 1998; Copenhagen 2009;
Glostrup 2006; Oslo 2000; Stockholm 1998; Trondheim 2000;
Trondheim 2004) or most patients (Belfast 2004) were recruited
from a stroke unit or neurological rehabilitation unit staffed by a
multidisciplinary team. Five trials (Bangkok 2002; London 1999;
Manchester 2001; Montreal 2000; Newcastle 1997) recruited a
minority of patients from a multidisciplinary stroke unit setting.
Therefore, the control service was frequently provided in general
wards.Discharge arrangementswere variable in the control services
with aminority undergoing a pre-discharge home visit and variable
follow-up arrangements.
Settings of services
The trials identified come from eight countries (Australia, Canada,
Denmark, Norway, Sweden, Thailand, UK, USA). Eleven trials
were established in city hospitals servicing largely urban areas while
two (Belfast 2004, Glostrup 2006 ) covered a mixture of rural and
urban areas. An additional trial (Trondheim 2004) recruited only
patients from rural addresses who were admitted to a large urban
hospital.
Patient characteristics
Patients had a clinical diagnosis of stroke and the average patient
age in the trials ranged from 66 to 80 years. There appeared to
be a degree of selection of patients deemed suitable for the early
supported discharge services that was based on need (persisting
disability), stability of their medical condition, and practicability
(living within the local area). The average (mean or median) initial
Barthel index (at the time of patient recruitment) in each study
ranged from 10/20 to 17/20 with a lower interquartile range limit
of 6 to 16/20 and an upper value of 14 to 19/20. Thus the typical
patient population had an initial Barthel index of 14/20 with an
interquartile range of 10 to 18.
We repeated this process to estimate the Barthel index at the time
of discharge for those trials where Barthel index was recorded
within one week prior to discharge (Adelaide 2000; Belfast 2004;
London 1999; Manchester 2001; Newcastle 1997; Trondheim
2000; Trondheim 2004). The average (mean or median) initial
Barthel index (within one week prior to discharge) in each study
ranged from 13/20 to 17/20 with a lower interquartile range limit
of 10 to 16/20 and an upper value of 15 to 19/20. Thus the typical
patient population prior to discharge had an initial Barthel index
of 15/20 with an interquartile range of 11 to 17.
None of the trials recruited more than 70% of hospitalised stroke
patients; a median of 34% (range 13% to 70%) of hospitalised
stroke patients met the clinical criteria for the early discharge ser-
vice (NB: in some trials, a further group of patients did not meet
research criteria such as an ability to complete research assess-
ments). Inclusion and exclusion criteria of individual trials have
been summarised in the Characteristics of included studies table.
Outcomes
Most trials included our main outcomes of death, residence (insti-
tutional care) and dependency (Barthel index or Rankin score), all
recorded at the end of scheduled follow-up, as well as our primary
resource outcome length of initial hospital stay (Table 2). Two
trials (Stockholm 1998; Trondheim 2000) reported outcomes of
death and dependency after scheduled follow-up (at one year and
five years).
Secondary outcomes included a range of measures which are sum-
marised in the Characteristics of included studies table and the
sampling analysis schedule provided in Table 3 and Table 4.
Excluded studies
See the Characteristics of excluded studies table.
Risk of bias in included studies
See the ’Risk of bias’ graph (Figure 2), the ’Risk of bias’ summary
(Figure 3) and the Characteristics of included studies table.
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Eleven trials (Adelaide 2000; Belfast 2004; Copenhagen 2009;
London 1999; Manchester 2001; Montreal 2000; Newcastle
1997; Oslo 2000; Stockholm 1998; Trondheim 2000; Trondheim
2004) used a clearly concealed randomisation procedure.
Blinding
Twelve trials (Adelaide 2000; Akershus 1998; Belfast 2004;
Copenhagen 2009; Glostrup 2006; London 1999; Manchester
2001; Montreal 2000; Oslo 2000; Stockholm 1998; Trondheim
2000; Trondheim 2004) used an independent (blinded) assess-
ment of outcomes at a fixed time after recruitment (median six
months; range three to 12months). Performance bias has not been
assessed as blinding of participants or treating personnel was im-
possible due to the nature of the intervention.
Incomplete outcome data
Those trials with published outcome data were generally complete
(see Results) at least for the main outcomes of death, institution-
alisation and dependency.
Effects of interventions
We analysed results for all comparisons of ESD services (policy
of early discharge with home-based support and rehabilitation)
versus conventional services (policy of hospital rehabilitation and
conventional discharge arrangements) at the end of scheduled fol-
low-up (median six months; range three to 12 months). We di-
vided services into three subgroups to reflect the pre-specified view
that effectiveness of ESD services may be influenced by the multi-
disciplinary teamwork of the ESD team responsible for post-dis-
charge care (see Description of studies). Therefore, we presented
the analysis in the following subgroups:
• ESD team co-ordination and delivery: co-ordinated
multidisciplinary ESD team co-ordinated and provided post-
discharge care;
• ESD team co-ordination: co-ordinated multidisciplinary
ESD team co-ordinated supervised discharge and immediate
post-discharge care but then handed over to other services;
• no ESD team: post-discharge services were not provided by
co-ordinated multidisciplinary ESD team.
The interpretation, timing and analysis of outcomes are shown in
Table 2, Table 3 and Table 4.
1. Patient outcomes
1.1: Death
Outcome data were available for all 14 trials (1957 patients). We
assumed patients with missing data (19 intervention patients and
10 controls) were alive. Overall there was no significant difference
in case-fatality between the ESD team and conventional services.
There was no significant degree of statistical heterogeneity with a
trend towards lower case fatality with the co-ordinated ESD team
subgroups (Analysis 1.1).
1.2: Death or requiring institutional care
Outcome data were available for 12 trials (1758 patients). We
assumed patients with missing data (19 intervention patients and
10 controls) were alive and living at home. Overall there was a
significant reduction in the odds of patients dying or requiring
long term institutional care (OR 0.78, 95% CI 0.61 to 1.00, P =
0.05) with no significant heterogeneity. This equates to an extra
four (zero to seven) patients living at home for every 100 treated
(Analysis 1.2).
1.3: Death or dependency
Outcome data were available for 14 trials (1957 patients). We as-
sumed patients with missing data (31 intervention patients and
25 controls) were alive and independent. Overall there was a sig-
nificant reduction in the odds of the combined adverse outcome
of death or dependency (OR 0.80, 95% CI 0.67 to 0.97, P =
0.02) with no significant heterogeneity. This equates to an extra
five (one to nine) patients regaining independence for every 100
receiving ESD services (Analysis 1.3).
1.4: Activities of daily living (ADL)
These data were available (in a variety of formats) for nine trials
(1124 patients). Overall there was no significant difference in the
ADL scores of survivors for whom data were available with no
significant heterogeneity (Analysis 1.4).
1.5: Extended activities of daily living
These data were available (in a variety of formats) for nine trials
(1051patients).Overall therewas an apparent increase in extended
ADL scores among survivors receiving ESD services (SMD 0.14;
95% CI 0.02 to 0.26, P = 0.02). These results were dependent on
data from the two subgroups of trials evaluating an ESD team (i.e.
no data were available from the two trials without a co-ordinated
ESD team (Akershus 1998; Bangkok 2002)) (Analysis 1.5).
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1.6: Subjective health status
These data were available (in a variety of formats) from 12 trials
(1377 patients). Overall there was no significant difference in the
subjective health status scores of both groups. There was no sig-
nificant degree of heterogeneity (Analysis 1.6).
1.7: Mood status
These data were available (in a variety of formats) from eight tri-
als (851 patients). Overall there was no significant difference in
mood scores. There was no significant heterogeneity. Additional
dichotomous data from one trial (London 1999) indicated that
the ESD service group were more likely to express anxiety (P =
0.02) and non-significant trends towards higher levels of depres-
sion (Analysis 1.7).
1.8: Patient satisfaction
These data were available (in a variety of formats) from five trials
(513 patients). Overall there was a pattern of ESD service patients
being significantly more likely to report satisfaction with outpa-
tient services or services in general (OR 1.60, 95% CI 1.08 to
2.38, P = 0.02). There was no significant heterogeneity (Analysis
1.8).
2. Duration of follow-up
Primary outcomes were recorded at the end of scheduled follow-
up (median sixmonths; range three to 12months). Two trials (403
patients) have reported extended outcome data subsequent to the
end of scheduled follow-up at one year and five years (Stockholm
1998, Trondheim 2000). There was a significant reduction in the
odds of the combined adverse outcome of death or dependency
censored at six months (OR 0.68; 95% CI 0.53 to 0.87; P =
0.002). Overall the pattern of a reduction in death or dependency
appears to be sustained at one year and five years but was no longer
significant (OR 0.84; 95% CI 0.66 to 1.05; P = 0.13 and OR
0.78; 95% CI 0.52 to 1.17; P = 0 .23 respectively) (Analysis 2.1;
Analysis 2.2; Analysis 2.3; Analysis 2.4; Analysis 2.5; Analysis 2.6).
3. Carer outcomes
3.1: Subjective health status
These data were available (in a variety of formats) from eight trials
(749 carers). Overall there was no significant difference in scores
and no significant heterogeneity (Analysis 3.1).
3.2: Mood status
These data were available from only two trials with 58 carers.
Overall there was no significant reduction in the mood score of
carers receiving ESD services but significant heterogeneity was
apparent between trials (Analysis 3.2).
3.3: Carer satisfaction
These data were available (in a variety of formats) from four trials
(279 carers). Overall there was no significant difference in the odds
of carers who received ESD services expressing satisfaction with
services (OR 1.56, 95% CI 0.87 to 2.81) (Analysis 3.3).
4. Resource use
(See: Analysis 4.1; Analysis 4.2)
4.1: Length of initial hospital stay
We were able to reanalyse data on length of initial hospital stay
(acute care and rehabilitation for index admission) for 13 trials
(1695 patients) (Analysis 4.1). Across all trials and within each
subgroup of trials, there was a significant reduction (P < 0.0001)
in the length of hospital stay, which is approximately equivalent to
seven days. Data were incomplete for total length of stay including
hospital readmissions. An analysis of the pattern of discharges
based on six trials that could provide data (Adelaide 2000, Belfast
2004, London 1999, Manchester 2001, Oslo 2000, Stockholm
1998) is shown in Table 5.
4.2: Hospital readmissions
Seven trials (918 patients) provided data on the number of pa-
tients readmitted to hospital after the index admission. Readmis-
sion rates during scheduled follow up (31% versus 28%) were very
similar between the ESD service and conventional care groups
(Analysis 4.2).
Costs
Costing data are currently available from seven trials (Table 6)
which estimated total costs up to three months (Montreal 2000),
sixmonths (Adelaide 2000;Newcastle 1997) or one year (Glostrup
2006; London 1999; Stockholm 1998; Trondheim 2000) after
randomisation. Estimated costs ranged from 23% less to 15%
greater for the ESD group in comparison to controls. These esti-
mates were reported to be stable in sensitivity analyses.
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Sensitivity analyses
Analyses by methodological characteristics
Analysis restricted to the 10 trials that were randomised at an in-
dividual patient level and reported concealed randomisation and
blinded follow-up showed a significant reduction in death or de-
pendency (OR 0.72, 95% CI 0.58 to 0.90, P = 0.004).
Subgroup analyses
Analyses by patient age and gender
Subgroup data for the primary outcome (death or dependency)
were available for at least nine trials. Smaller amounts of data were
available for death, death or institutionalisation, and length of stay.
There was no significant association of patient age or gender with
the apparent effect of the ESD service (Analysis 5.1; Analysis 5.2;
Analysis 6.1; Analysis 6.2).
Analyses by initial stroke severity
Datawere available for 11 trials (1545 patients). Subgroup analysis
by initial stroke severity revealed a greater reduction (P = 0.04) in
odds of death or dependency (OR 0.77, 95% CI 0.61 to 0.98) in
patients with moderate initial stroke severity (initial Barthel Index
of > 9/20) than those in the severe subgroup (OR 1.40, 95% CI
0.83 to 2.36). Similar patterns of results were seen for the outcome
death or institutional care. The reduction in length of hospital
stay was much greater (P < 0.0001) for the severe stroke subgroup
(MD 28 days, 95% CI 17 to 40) than the moderate group (MD 3
days, 95% CI 1 to 7). Similar results were obtained if the Barthel
index at randomisation was used from the two trials (Adelaide
2000; London 1999) that randomised patients up to several weeks
after stroke (Analysis 7.1; Analysis 7.2).
These results suggest that the greatest benefit in clinical outcomes
was with the mild and moderate groups but the greatest reduction
in hospital bed days was with the severe subgroup.
Analyses by carer availability
Ten trials (1237 patients) could provide subgroup data on the
availability of a carer. There was no apparent interaction of ESD
service effect with the presence of a carer (Analysis 8.1; Analysis
8.2).
Analyses by ESD service organisation
The ESD services studied were classified according to the organ-
isation of the multidisciplinary team (see Description of studies).
There was a significant subgroup interaction (P = 0.04) by ESD
characteristics. The trials with a co-ordinated multidisciplinary
ESD team showed an odds of death or dependency of OR 0.73
(95% CI 0.59 to 0.90) compared with OR 1.23 (95% CI 0.79 to
1.91) in those without an ESD team. There was no significant in-
teraction with the background service (stroke unit or other ward)
or the base for the ESD team (community in-reach or hospital out-
reach). The reduction in length of hospital stay was more marked
in the hospital out-reach group (MD 10 days, 95% CI 1 to 18)
than the community in-reach group (MD 4 days, 95% CI 1 to 7)
but this was not statistically significant (P = 0.24) (Analysis 9.1;
Analysis 9.2; Analysis 10.3; Analysis 10.4; Analysis 11.1; Analysis
11.2).
The staffing levels of each service did not differ sufficiently to allow
meaningful subgroup analyses based on staff mix, service intensity
and supportive versus rehabilitative interventions.
Analyses by control service organisation
Subgroup analyses were carried out according to the background
(control) service available; stroke unit or otherward.Therewere no
apparent interactions with control service characteristics (Analysis
11.1; Analysis 11.2).
Analysis of ’core’ ESD services
Some commentators have criticised the original inclusion of trials
(Akershus 1998; Bangkok 2002) that did not incorporate a ro-
bust multidisciplinary rehabilitation programme in the commu-
nity. The remaining 12 trials are much more typical of what has
become accepted as a ’core’ ESD service (Fisher 2011). If the anal-
yses are restricted to those 12 trials the results are more convinc-
ing for ESD services: death (OR 0.77, 95% CI 0.54 to 1.09; P =
0.14) (Analysis 10.1), death or institutional care (OR 0.69, 95%
CI 0.53 to 0.91; P = 0.008) (Analysis 10.2), death or dependency
(OR 0.73, 95% CI 0.59 to 0.90; P = 0.003) (Analysis 10.3) and
reduction in length of stay (MD 8 days; 95% CI 4 to 11; P <
0.0001) (Analysis 10.4).
D I S C U S S I O N
Summary of main results
It is clear from this analysis of the randomised trials that services
aiming to accelerate discharge from hospital can bring about a
reduction in the length of hospital stay and that this reduction can
be substantial. This updated individual patient data analysis now
demonstrates that patients receiving ESD services weremore likely
to be independent and living at home six months after stroke than
those who received conventional services. ESD patients scored
better on extended ADL scores and were more likely to express
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satisfaction with services. Although we have limited information
available, we have been unable to confirm earlier concerns about
the impact of ESD services on the mood and well being of carers
(in terms of subjective health score, mood or satisfaction with
services).
Economic analyses were carried out in seven trials. Although the
underlying costs and assumptions were different for each analysis,
all concluded that the opportunity savings from hospital bed days
released tended to be greater than, or similar to, the cost of the
ESD service. Realising such cost savings in practice can be difficult
but ESD services appear to offer one way tomanage rising demand
for a finite number of hospital beds.
The particular component of an ESD service responsible for the
improvement in functional outcome seen remains unclear. Pro-
viding rehabilitation in the setting of the patients’ own home is
thought to be a significant contributing factor. It has also been sug-
gested that patients receiving ESD services overall receive greater
input from rehabilitation therapists and for a longer duration than
those receiving conventional care. However, any potential increase
in rehabilitation input does not appear to affect overall cost-effi-
cacy of ESD services in economic analyses.
In conclusion, appropriately resourced and co-ordinated ESD
teams can offer a further effective service option for a selected
group of stroke patients and should be considered in addition to
organised inpatient (stroke unit) care as part of a comprehensive
stroke service.
Overall completeness and applicability of
evidence
When interpreting the results of this review it is important to re-
member that the basic question addressed was whether a policy of
early hospital discharge with support could be as effective and ef-
ficient as conventional care. Therefore, our inclusion criteria were
broad and focused on trials that compared two policies of care
for stroke patients in hospital: (1) conventional care, i.e. the usual
hospital care and discharge procedures; and (2) an alternative sys-
tem of care which aimed to provide an earlier discharge with re-
habilitation or support, or both, in a home-based setting (’early
supported discharge’ (ESD)). Within this broad question we an-
ticipated that a ’core’ group of trials would be testing a specialist
multidisciplinary ESD team that had been established to provide
this form of care to stroke patients. However, we also wished to
retain the option of including other trials where a policy of early
discharge was tested in other ways. The advantage of this broad
approach is that it can allow us to examine both the effectiveness
of a reasonably specific co-ordinated ESD team ’package’ of care,
and also to explore the broader issues of which service factors (both
inpatient and outpatient) may influence patient outcomes. One
potential hazard is that it is difficult to conduct such an exercise
in a truly a priori and objective manner.
In developing a clear question to guide this review, we have cho-
sen to focus on the intention of the service intervention and to
avoid terms such as ’hospital at home’ which may have a different
meaning to different people. However, we should acknowledge
that some services (Wade 1985) aim to both help avoid hospi-
tal admission and accelerate discharge. We have not excluded any
trials from the review solely on the basis of their service having
this dual function. We have also focused the review on services for
stroke patients. There are several potentially complementary trials
that have recruited a mixed geriatric medical patient population.
These have recently been reviewed (Shepperd 2009).
Quality of the evidence
This update identified three new trials (360 patients) and did not
alter overall conclusions in comparison with the previous version
of the review. While we acknowledge that the total amount of data
available is limited (14 trials; 1957 patients) there do appear to be
some general conclusions which can be drawn.
1. Most of the evidence of benefit of ESD services come from
trials of a multidisciplinary ESD team whose work is co-
ordinated through regular meetings.
2. The typical multidisciplinary ESD team comprised
physiotherapy, occupational therapy and speech and language
therapy staff with medical, nursing and social work support.
3. Such services appeared to be effective even in comparison
with a standard service based on care in a stroke unit.
4. Although we could not find evidence that the setting of the
service (hospital out-reach or community in-reach) influenced
outcomes, all the ESD teams reported here had a specialist
interest in stroke or rehabilitation, or both.
5. All trials recruited a selected subgroup (on average 34%) of
stroke patients usually living in an urban setting. There is
insufficient evidence to draw conclusions on ESD services for
patients living in a more dispersed rural setting.
6. Most of the evidence of ESD benefit appears to be for
patients with moderate disability (initial Barthel index of > 9/
20), although the balance of cost and benefit is not clear for this
subgroup. For patients with more severe disability the substantial
saving in bed-days may well be outweighed by a risk of poorer
patient outcomes. We, therefore, cannot exclude the possibility
that the clinical benefits enjoyed by the moderate disability
subgroup required a net increase in rehabilitation input while the
main cost savings (in terms of bed days) came from the severe
subgroup.
Although the quality of the evidence in general was good, the ma-
jority of trials were completed over 10 years ago. Inmany countries
the last decade has seen a significant overhaul of stroke services
to enable greater access to hyperacute therapies (e.g. intravenous
thrombolysis).However, only a small proportion of stroke patients
will be eligible for such therapies, with the vast majority contin-
14Services for reducing duration of hospital care for acute stroke patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
uing to rely on post-stroke rehabilitation to improve functional
outcomes.
The conclusions about the potential benefit of ESDservices appear
to be robust. The results are strengthened if analyses focus on trials
with clearly concealed randomisation and blinded follow-up (10
trials; 1314 patients), or on the ’core’ group of trials testing a co-
ordinated ESD team.
Potential biases in the review process
Through a thorough searching process and well established per-
sonal connections with researchers in this field we are confident
that we should have identified all potentially relevant studies.
However, for two studies (ATTENDpilot trial 2011; Edirne2001)
we did not have sufficient information to classify according to our
inclusion criteria. We realise the absence of data from these studies
in our meta-analysis may potentially have introduced bias.
As discussed, our inclusion criteria with respect to the service in-
tervention were deliberately broad. We recognise that interpreta-
tion of patient and service characteristics raises the potential risk
of a post-hoc explanation of results. However, we have tried as far
as possible to plan analyses a priori.
For a small proportion of patients data were missing for our di-
chotomous outcomes of death (19 intervention patients; 10 con-
trols), death or institutionalisation (19 intervention patients; 10
controls) and death or dependency (31 intervention patients; 25
controls). In these instances we assumed the patients to be alive
and independent. Similarly for continuous outcome data, where
standard deviations were not reported they were inferred from the
interquartile ranges or alternatively estimated as being at least as
large as the comparable trials using the samemeasure (seeMeasures
of treatment effect). Whilst we recognise that this may have intro-
duced potential bias to our results, we believe that including im-
puted and estimated data were preferable to excluding data from
patients or studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Selected stroke patients in hospital who received input from an
ESD service returned home earlier than those receiving conven-
tional care. They were also more likely to be independent and
living at home six months after their stroke and to express satis-
faction with the services they received. There were no apparent
adverse effects on the subjective health status or mood of patients
or carers. The apparent benefits of ESD services are largely derived
from trials of services provided by co-ordinated ESD teams and
recruiting patients with less severe disability.
Although clarity around the specific model of ESD is required,
the evidence summarised is sufficient to provide support for im-
plementation of stroke ESD services as part of a comprehensive
system of stroke care. Thus, a consensus on key elements of an
ESD service has been developed by the original trialists to facili-
tate successful implementation at a national and international level
(Fisher 2011).
Implications for research
Our conclusions are based on a relatively small number of trials.
More research is required to define the important characteristics
of effective ESD services and to define the balance of cost and ben-
efit for different patient and service groups. Contemporary trials
would provide data on resource use and functional outcome in an
era with greater access to thrombolytic therapy. Further research
is required to establish if more generic ESD teams (e.g. services
for a mixed elderly population) will obtain the same results as the
stroke-specific services reported here. The role of ESD services in
poorer healthcare settings and in more dispersed rural communi-
ties has not really been adequately addressed.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adelaide 2000
Methods RCT
Randomisation using opaque sealed envelopes
Independent (single blind) follow-up
Participants 86 patients recruited from city hospital
Inclusion criteria: clinical diagnosis of stroke in previous 6 months, requiring rehabilita-
tion, needing light/moderate assistance with transfers, medically stable, living at a local
address with adequate community support
Characteristics: mean age 72 years (SD 11), median BI 85/100 (IQR 80 to 95). Trial
included 86/398 (22%) of stroke patients admitted to hospital
Interventions Intervention: multidisciplinary community rehabilitation team, comprising medical,
physiotherapy, occupational therapy, speech and language therapy and social work input.
Combination of hospital in-reach and community out-reach services. Input initially
intensive and then tapered off to stop when rehabilitation goals were met. Team had
specialist interest in rehabilitation and their activities were co-ordinated through weekly
multidisciplinary meetings. Team co-ordinated and delivered care
Control: these patients received conventional rehabilitation in a neurological rehabilita-
tion unit with specialist interests in stroke and neurological disability. Controls received
multidisciplinary care co-ordinated through weekly meetings
For both groups, discharge was frequently planned with pre-discharge home visits
Outcomes Outcomes recorded at 6 months: death, place of residence, dependency (modified BI,
Adelaide Activities Profile), subjective health status (SF36), carer subjective health status
(SF36, GHQ 28), patient and carer views (McMaster Family Assessment of recovery)
Notes Intervention focused on patient’s own identified goals and received longer contact with
the ESD therapy team
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “... contact by telephone for the allo-
cation sequence which was computer gen-
erated”
Allocation concealment (selection bias) Low risk Quote “opaque sealed envelopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote “independent of ... unaware of treat-
ment allocation”
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Adelaide 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported
Akershus 1998
Methods RCT (exact methods unclear)
Independent (single blind) follow-up
Participants 251 patients recruited from city hospital
Inclusion criteria: clinical definition of stroke, age greater than or equal to 60 years of
age, SSS 12 to 52, conscious and able to co-operate with rehabilitation, living at private
address
Characteristics: mean age 75 (SD 6) years. Initial BI a median of 50/100 (IQR 30 to
70). A total of 238/550 (43%) of the patients screened were recruited
Interventions Intervention: community rehabilitation provided by a variety of municipality-based re-
habilitation services (41% admitted to nursing homes for rehabilitation, 25% received
ambulatory physiotherapy, 4% speech therapy, 30% no treatment). Community reha-
bilitation services did not specialise in stroke and were not consistently co-ordinated
through regularmultidisciplinary teammeetings.Medical input fromprimary care physi-
cian with variable degree of nursing input
Control: control patients received conventional inpatient rehabilitation in a 6-bed bay of
a rehabilitation unit. This comprised multidisciplinary rehabilitation provided by staff
with a specialist interest in stroke rehabilitation and co-ordinated through weekly team
meetings
Outcomes Outcomes recorded at 7 months: death, place of residence, impairment (SSS), depen-
dency (BI: in current analysis dependency = BI < 15/20), subjective health status (SF36)
, resource use (length of stay)
Notes This trial was set up as an evaluation of the stroke rehabilitation ward with municipality
services acting as controls
7 intervention and 12 control patients could not be contacted at 7 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote “patients were given a random num-
ber ... a person not involved in the study
drew numbers for allocation”
However, if the rehabilitationwardwas full,
patients randomised to this ’intervention’
were assigned the control i.e. rehabilitation
in the municipality (13 patients)
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Akershus 1998 (Continued)
Allocation concealment (selection bias) Unclear risk “a person not involved in the study drew
numbers for allocation”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “who was unaware of where the patients
had been treated”
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported
Bangkok 2002
Methods RCT (exact methods unclear)
Unblinded outcome assessments
Participants 102 acute stroke patients presenting to a city hospital
Inclusion criteria: ischaemic stroke within 48 hours of onset; age 18 to 80 years
Exclusion criteria: altered consciousness (NIHSS > 20), large infarct, embolic cause;
aphasia
Interventions Intervention: discharge on 4th day to home care programme managed by Red Cross
volunteers. Visit on day 3 then alternate day visits for 1 week, then visits on week 2,
month 1, 3 and 6. Volunteers trained in stroke, simple rehabilitation and detection of
complications. Volunteers reported back to nursing staff
Control: managed in neurological or medical department for up to 10 days
Outcomes Outcomes recorded at 6 months: death, dependency (NIHSS 0 to 2, BI 75 to 100),
patient satisfaction
Notes Same treatment during first 3 days
Nadroparin given for 10 days
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “patients were randomised into two
groups”
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not re-
ported
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessments were based on data
from neurologist or Red Cross volunteer
who were aware of treatment allocation
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Bangkok 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “102 patients were studied”
No information is provided onwithdrawals
or those who did meet inclusion criteria,
etc
Selective reporting (reporting bias) Low risk All pre-specified outcomes have been re-
ported
Belfast 2004
Methods RCT
Central randomisation system using random number sequence
Independent (single blind) follow-up
Participants 113 hospitalised stroke patients within 3 weeks of onset
Exclusion criteria: medically unstable, no rehabilitation needs
Characteristics: age 68 (SD 12) years, male 55%, baseline BI 14/20 (SD 4)
Interventions Intervention: community rehabilitation in-reach team with specialist interest in reha-
bilitation. Team consisted of physiotherapy, occupational therapy, speech and language
therapy, support staff and medical input. Work was co-ordinated through weekly team
meetings. Planning often included pre-discharge home visit. Team co-ordinated and de-
livered care
Control: conventional care comprised medical ward, geriatric medical ward, and stroke
unit services. The majority of these patients were managed by a multidisciplinary team
with a specialist interest in stroke and rehabilitation, which was co-ordinated through
weekly multidisciplinary team meetings and often included pre-discharge home visits.
Occasional day hospital follow-up
Outcomes Outcomes recorded at 6 and 12 months: death, place of residence, dependency (mod-
ified Rankin score, Nottingham extended ADL score), subjective health status (SF36,
Euroquol), carer health status (caregiver strain), patient and carer preference
Notes Main difference reported was that the intervention provided continuity of rehabilitation
in community setting
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “computer generated randomly assigned
care options”
Allocation concealment (selection bias) Low risk “administered solely by a named secretary.
No research team member ... had access to
this list”
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Belfast 2004 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “research nurses were blind at baseline to
the particular group”
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported
Copenhagen 2009
Methods RCT
External list generated and managed by external person, blocks of 10
Opaque sealed envelopes
Participants 100 patients recruited from stroke unit of 1 university hospital, 1 to 3 days post stroke
Inclusion criteria: mRS 0 to 3 pre-stroke, living at home
Median age 81 (range 33 to 98) years, median BI 69 (0 to 100), median SSS 45 (11 to
58)
Interventions Hospital out-reach multidisciplinary team, based within stroke unit. Co-ordinated and
delivered low intensity (1 to 3 times per week) home based rehabilitation for a period of 1
month. All staff were skilled in stroke care and co-ordinated via weekly multidisciplinary
meetings
Control: conventional discharge planning from combined acute/rehabilitation stroke
unit and conventional after discharge care
Outcomes At 90 days: dependency (mRS, BI, MAS, COPM), cognition (CT-50), quality of life
(EQ-5D)
At 150 days: mortality, use ofmunicipal services, hospital contacts, cost, carer satisfaction
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Unpublished: ’External list generated and
managed by external person’
Allocation concealment (selection bias) Low risk Unpublished: ’Opaque sealed envelopes’
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Unpublished: blinded outcome assessment
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Copenhagen 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 7 patients in the intervention group and
3 control patients ’dropped out’ prior to
discharge andwere not included in the final
analysis
Selective reporting (reporting bias) Low risk All pre-specified outcomes appear to have
been reported (unpublished)
Glostrup 2006
Methods Cluster randomised trial
6municipalities each divided into 2 parts and then computer randomised to intervention
or control
Participants 198 patients with acute stroke (World Health Organization definition) requiring at least
7 days hospital stay recruited from 1 university hospital
Exclusion criteria: death in hospital, discharge to 24-hour nursing facility, severe co-
morbidity, aphasia
Charachteristics: mean age 71 years (range 38 to 96), approximately 50% in each group
had no impairment on initial BI
Trial included 198/410 patients screened (48%)
Interventions All patients were discharged from a mixed geriatric/neurology rehabilitation unit with
staff skilled in stroke care
Intervention: multidisciplinary stroke team comprised of physiotherapist, occupational
therapist and physician who made contact with patient during hospital stay, facilitated
discharge including pre-assessment home visit and provided therapy in the community
for a total of 30 days (maximum 10 home visits). Team co-ordinated and delivered care
and were co-ordinated through multidisciplinary meetings (frequency uncertain)
Control: conventional discharge planning and after discharge services including home
care services, day care centre and physiotherapy
Outcomes Outcomes at 6 months: dependency (BI, Frenchay Activities Index), cognition (MMSE,
CT-50), mood (GDS), subjective health status (SF-36)
At 12 months: data on use of public health services (e.g. home-care services), hospital
re-admissions, outpatient visits and death
Notes Some patients initially randomised were not included in the final analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Cluster randomisation of municipality di-
vided into 2 parts a-priori
Quote: “by computer generated random
numbers”
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Glostrup 2006 (Continued)
Allocation concealment (selection bias) High risk Quote: “by computer generated random
numbers”
Quote: “this way all patients were pre-ran-
domised according to their address”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “independent therapists not aware
of patients randomisation performed out-
come assessments after 26 weeks”
Incomplete outcome data (attrition bias)
All outcomes
High risk 75 patients in the intervention group and
87 control patients were excluded from the
analysis prior to discharge
Selective reporting (reporting bias) Low risk All available outcome assessments have
been reported
London 1999
Methods RCT
Permuted blocks of 10 provided in blank sealed opaque envelopes
Final (12-month assessment) was blinded to treatment allocation
Participants 331 patients recruited from 2 city hospitals
Inclusion criteria: patients were medically stable, lived alone and were able to transfer
independently (or could be transferred by a resident carer)
Characteristics: mean age 71 years (range 27 to 103). Initial BI 15 to 19/20 in approxi-
mately 50% of patients
331 patients randomised out of over 660 screened (approximately 45% of patients were
recruited)
Interventions Intervention: multidisciplinary community therapy team comprising physiotherapy, oc-
cupational therapy, speech and language therapy and medical input. The team had a
special interest in neurology and stroke and were co-ordinated through weekly multi-
disciplinary meetings. The community team liaised with hospital based rehabilitation
staff and then provided a package of care after discharge. The maximum duration of the
intervention was 3 months. Team co-ordinated and delivered care
Control: these patients received conventional care (less than 50% managed in co-or-
dinated multidisciplinary stroke units) with conventional discharge planning and post
discharge support
Outcomes Main outcomes recorded at 12 months (additional details at 2, 4 and 6 months): death,
place of residence, dependency (BI, Frenchay activities index, Rivermead ADL score;
in current analysis dependency = BI < 20/20), subjective health status (Nottingham
Health Profile), patient mood (Hospital anxiety and depression scale), carer health status
(caregiver strain), patient and carer satisfaction, resource use (hospital length of stay,
place of residence, number of therapy sessions)
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London 1999 (Continued)
Notes Important characteristics were believed to be providing a co-ordinated package of com-
munity rehabilitation
5 intervention and 4 control patients lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “permuted blocks of ten with ran-
dom number tables”
Allocation concealment (selection bias) Low risk Quote: “blank opaque sealed envelopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “by a researcher blinded to which
arm of the trial”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data were balanced in
numbers across groups (5 patients in inter-
vention group and 4 control patients were
lost to follow-up) with similar reasons for
withdrawal and proportionally unlikely to
have impact
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported
Manchester 2001
Methods RCT of inpatient stroke team and home team
Home team arm consists of early discharge trial
Stratified randomisation conducted from offsite trials office
Blinded outcome assessment
Participants 23 patients admitted to 2 city hospitals within 7 days of onset of clinical stroke
Medically stable
Characteristics: mean age 66 (SD 9) years. Males 18 (77%). Initial BI 15/20 (SD 6)
Interventions Intervention: community-based, nurse-led, stroke-specific multidisciplinary team (nurs-
ing, physiotherapy, occupational therapy, speech and language therapy). Patients assessed
pre-discharge and allocated up to daily input at home for up to 3 months
Control: conventional discharge planning by mobile stroke team or hospital stroke unit
Outcomes Outcomes at 12 months: death, place of residence, dependency (BI, Nottingham EADL
score, Euroquol, Sickness Impact Profile 30, HADS, Carer HADS and caregiver burden
scale)
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Manchester 2001 (Continued)
Notes Trial terminated early after the withdrawal of 1 hospital and difficulty recruiting new
staff
2 intervention and 1 control patient lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote fromprotocol only: “TheCentre for
Cancer Epidemiology Trials Unit will gen-
erate the randomisation schedule”
Allocation concealment (selection bias) Low risk Quote from protocol only: “this schedule
will be concealed from clinicians”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote from protocol only: “will be con-
cealed from ... therapists undertaking fol-
low-up assessments”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information tomake a decision
as to ’low-risk’ or ’high-risk’
Selective reporting (reporting bias) Unclear risk Insufficient information tomake a decision
as to ’low-risk’ or ’high-risk’
Montreal 2000
Methods RCT
Telephone randomisation using opaque sealed envelopes held in a central office
Single blinding of outcome assessment
Participants 114 patients recruited from 5 city hospitals
Inclusion criteria: clinical diagnosis of stroke in the previous 28 days (mean delay 10
days), moderate disability, living with carer, medically stable
Characteristics: mean age 70 (SD 13) years, mean BI 83/100 (SD 14). Trial included
164/1321 (13%) of patients screened
Interventions Intervention: community rehabilitation team providing intensive home rehabilitation.
Team comprised nursing, physiotherapy, occupational therapy, speech therapy and di-
etitian input. Intervention was co-ordinated and individualised. Intervention lasted 4
weeks with further care as required. Team co-ordinated and delivered care
Control: conventional care incorporated a variety of inpatient services (owing to health
care cutbacks, only 27% of control patients received home care or rehabilitation centre
care)
Outcomes Outcomes recorded at 3months: death, place of residence, dependency (BI, instrumental
ADL), subjective health status (SF36), service costs
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Montreal 2000 (Continued)
Notes Health service changes during the study resulted in an increase in community services and
reduction in inpatient facilities forcing earlier discharges on conventional care patients.
As a result, the intervention group received an increased rehabilitation input
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “block sizes that varied from 4 to 8 ... in
the central office, group assignment was re-
vealed over the telephone”
Allocation concealment (selection bias) Low risk “opaque sealed envelopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “who were not informed about group as-
signment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis
Selective reporting (reporting bias) Low risk Pre-specified outcomes reported
Newcastle 1997
Methods RCT
Zelen randomisation procedure using a computerised randomisation system, accessed
by telephone
Independent (single blind) follow-up of patients but security of blinding uncertain
ITT analysis
Participants 92 stroke patients recruited from 3 city hospitals
Inclusion criteria: within 3 days of stroke, BI 5 to 19, medically stable, living at private
address
Characteristics: median age 73 (44 to 93) years. Median BI 14/20 (range 2 to 20) at 1
week post-stroke. 119/402 (30%) of patients screened were recruited
Interventions Intervention: community-based hospital in-reach multidisciplinary rehabilitation team
with a specialist interest in stroke and co-ordinated through weekly multidisciplinary
meetings. Medical support by general practitioner and stroke physician. Rehabilitation
team contacted patients and carers and carried out assessment of home circumstances
prior to discharge. Following discharge, daily therapy and home care could be provided
if required. Median duration of input was 9 weeks (range 1 to 44 weeks). Team co-
ordinated and delivered care
Control: these patients received conventional hospital care, usually provided in general
medical wards (less than half the patients received organised multidisciplinary stroke
unit care)
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Newcastle 1997 (Continued)
Outcomes Outcomes recorded at 3, 6 and 12months after randomisation: death, place of residence,
dependency (Rankin score, Nottingham extended ADL; in current analysis dependency
= Rankin score > 2, approximately equivalent to a BI < 19/20), subjective health status
(COOP charts), mood status (Wakefield depression inventory), carer subjective health
status (GHQ 30), patient and carer preferences (qualitative interviews), resource use
(length of hospital stay, costing of services)
Notes Staff felt that continuity of care provided in the home environment were key elements
1 intervention and 3 control patients lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “central computerised randomisa-
tion service”
Allocation concealment (selection bias) Low risk Central allocation. Quote: “central com-
puterised randomisation service”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: “blinding to the randomisation
group was not possible as it soon became
apparent at the discharge interview”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All withdrawals explained, ITTanalysis fol-
lowed
Selective reporting (reporting bias) Low risk All pre-specified outcome measures re-
ported.
Oslo 2000
Methods RCT
Zelen’s randomisation method (stratified for urinary incontinence)
Concealed allocation
Blinded outcome assessment
Participants 82 stroke patients admitted to an acute stroke unit in a city hospital
Inclusion criteria: onset < 6 days, home dwelling, no prior disability, no major co-
morbidity, BI 5 to 19 at 72 hours after the stroke
Exclusion criteria: subarachnoid haemorrhage, cognitive or communication problems
Characteristics: mean age 78 (SD 9) years, male 45%, baseline BI 14/20 (SD 5)
Interventions Intervention: multidisciplinary team , experienced in stroke rehabilitation (nurse, phys-
iotherapist, occupational therapist) visited patient in hospital, prepared discharge and
co-ordinated rehabilitation. Rehabilitation at home provided by both the team and com-
munity services. Input as long as required
Control: acute care and rehabilitation in co-ordinated multidisciplinary stroke units
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Oslo 2000 (Continued)
Outcomes Outcomes recorded at 6 months: death, residence, Nottingham extended ADL scale,
General Health Questionnaire, depression, resource use
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “block randomised by computer
generated numbers”
Allocation concealment (selection bias) Low risk Quote: “sealed envelopes ... sequentially
opened”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All assessments performed by a specially
trained nurse “... whowas neither informed
about the intention nor the design or hy-
pothesis of the study”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5 patients in the intervention group and
6 control patients were lost to follow-up
by 3 months; ITT analysis followed for all
dichotomous variables
Selective reporting (reporting bias) Low risk All pre-specified outcomes have been re-
ported
Stockholm 1998
Methods RCT
Opaque sealed envelopes
Independent (single blind) outcome measurement
Participants 83 patients recruited from the neurology department of a city hospital
Inclusion criteria: cerebral infarct or primary intracerebral haemorrhage, 5 to 7 days
post stroke, continent and able to feed, residual impairment, medically stable, intact
cognition
Characteristics: median age 72 (range 49 to 89) years.Median LindmarkMotor Capacity
scale 127/153 (IQR 100 to 138). Trial included 86/220 (38%) of patients screened
(approximately 30% of all patients)
Interventions Intervention: multidisciplinary hospital out-reach early supported discharge team, with
special interest in rehabilitation and co-ordinated through weekly meetings. This was a
therapist based service (no nursing input) based in the hospital stroke unit. Pre-discharge
home visit carried out with the patient. Intervention provided on a less than daily basis
for 3 to 4 months after discharge. Team co-ordinated and delivered care
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Stockholm 1998 (Continued)
Control: these patients received conventional hospital care involving co- ordinated mul-
tidisciplinary stroke unit care in a hospital stroke unit and conventional discharge pro-
cedures
Outcomes Outcomes measured at 3, 6 and 12 months: death, place of residence, dependency (Katz
ADL, BI, Frenchay Activities Index; in the current analysis dependency = BI < 20/20),
subjective health status (Sickness impact profile), carer subjective health status (Sickness
impact profile), patient and carer satisfaction, resource use (length of stay and service
costs)
Outcome assessment was repeated again at 5 years - including resource use
Notes Team felt that co-ordinated continuity of care provided at home was the key element
1 intervention and 1 control patient lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “blocks of two or four, ... by a com-
puterized random procedure”
Allocation concealment (selection bias) Low risk “sealed numbered envelopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “assessors were blinded with respect to
group assignment and were not involved in
randomisation”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All withdrawals explained
Selective reporting (reporting bias) Low risk All prespecified outcomes reported at 1 year
Trondheim 2000
Methods RCT
Opaque sealed envelopes
Participants 320 unselected acute stroke patients admitted to a stroke unit providing acute care and
early rehabilitation
Inclusion: acute stroke (< 7 days) patients screened within 3 days of admission
Exclusion: coma (SSS < 2) or full recovery (SSS > 57)
Characteristics: mean age 74 years, 53% male, mean BI 60/100, mean SSS 43/58. Trial
included 320/468 (68%) of admissions
Interventions Intervention: hospital out-reach stroke team (nurse, physiotherapy, occupational ther-
apy) based in the stroke unit who made contact with patients in hospital, arranged dis-
charge to home or rehabilitation unit, co-ordinated rehabilitation and support services
and provided follow up. Variable duration of input. Team co-ordinated care which was
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Trondheim 2000 (Continued)
largely delivered by other agencies
Control: conventional procedures with acute care and early rehabilitation in a stroke
unit, and discharge home or to a rehabilitation unit
Outcomes Outcomes measured at 6 weeks, 6 months and 12 months: death, place of residence, BI,
Rankin score, Frenchay Activity Index, initial (stroke unit) length of stay, total (stroke
unit + rehabilitation) length of stay
Further outcomes at 12 months: Nottingham Health Profile, MMSE, Montgomery-
Asberg Depression Scale, Caregivers Strain index, cost analysis
Notes Outcomes repeated after 5 years: death, place of residence, Rankin score, BI, Frenchay
Activity Index, SSS, MMSE
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomisation was restricted in permuted
blocks with random number tables”
Allocation concealment (selection bias) Low risk Quote: “sealed opaque envelopes”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “all assessments were blinded as far as is pos-
sible in such a trial”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All missing data are explained
Selective reporting (reporting bias) Unclear risk All pre-specified outcomes reported
Trondheim 2004
Methods RCT
Opaque sealed envelopes
Participants 62 patients admitted to the stroke unit (acute care and early rehabilitation) who were
resident in a rural community (30 to 90 minutes driving distance from hospital)
Inclusion: acute stroke (< 7 days) patients screened within 3 days of admission
Exclusion: coma (SSS < 2) or full recovery (SSS > 57)
Characteristics: mean age 76 years, mean BI 56/100, mean SSS 43/58. Trial included
62/89 (70%) of admissions
Interventions Intervention: hospital out-reach stroke team (physiotherapy, occupational therapy, nurse)
based in the stroke unit who made contact with patients in hospital, arranged discharge
to home or rehabilitation unit, co-ordinated rehabilitation and support services and pro-
vided follow-up. Team co-ordinated care which was largely delivered by other agencies.
Primary care provider assisted with co-ordination of discharge home for patients living
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Trondheim 2004 (Continued)
further than 45 minute driving distance from the hospital. ESD co-ordination for 4 to
6 weeks, terminated by outpatient consultation (30 to 45 minutes driving distance) or
home visit (> 45 minutes driving distance)
Control: conventional procedures with acute care and early rehabilitation in a stroke
unit, and discharge home or to a rehabilitation unit
Outcomes Outcomes measured at 6, 26 and 52 weeks: Modified Rankin Score, BI, Nottingham
Health Profile, Caregiver Strain Index, death, initial (stroke unit) length of stay, total
(stroke unit + rehabilitation) length of stay
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ’patients ... were block randomised in blocks
of four, six or eight .... The order of the blocks was
randomly chosen’
Allocation concealment (selection bias) Low risk Sealed opaque envelopes by an external office
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: ’An independent and blinded assessor’ ... per-
formed all outcome measures
Incomplete outcome data (attrition bias)
All outcomes
Low risk All withdrawals or missing data are explained
Selective reporting (reporting bias) Low risk All pre-specified outcomes are reported
ADL: activities of daily living
BI: Barthel Index
COOP: Care Cooperative Information Project
COPM: Canadian Occupational Performance measure
EADL: extended activities of daily living
ESD: early supported discharge
EUROQOL / EQ-5D: European Quality of Life instrument
GDS: Geriatric Depression Scale
GHQ: General Health Questionnaire
HADS: Hospital Anxiety and Depression Scale
hrs: hours
IQR: interquartile range
ITT: intention-to-treat
MAS: Motor assessment scale
MMSE: Mini Mental State Examination
NIHSS: National Institute of Health Stroke Scale
RCT: randomised controlled trial
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SD: standard deviation
SF36: Short Form 36
SSS: Scandinavian Stroke Scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Asplund 2000 Patients had a variety of diagnoses
Auckland 1999 Study was planned but did not commence recruitment
Ayrshire 2000 Study was planned and funded but did not commence recruitment
Challis 1991 Patients had a variety of diagnoses
Non-randomised trial
Cumbria 2004 Study was planned but did not commence recruitment
Donald 1995 Patients had a variety of diagnoses
Dunn 1994 Patients had a variety of diagnoses
Gladman 2001 Patients had a variety of diagnoses
Grasel 2005 Non-randomised trial
Kalra 2000 Service to prevent admission to hospital
LHEC 1997 Patients had a variety of diagnoses
Lincoln 2004 Community setting
Mackay 1995 Late rehabilitation intervention
Martin 1994 Patients had a variety of diagnoses
New York 1986 No outcome data available (unable to contact authors)
Ricauda 2004 Service aimed to prevent hospital admission (patients did not leave hospital emergency room)
Shepperd 1998 Service to prevent admission to hospital
Patients had a variety of diagnoses
Townsend 1998 Patients had a variety of diagnoses
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(Continued)
Victor 1988 Patients had a variety of diagnoses
Non-randomised trial
Wade 1985 Service to prevent hospital admission as well as accelerate discharge
Non-randomised trial
Weiss 2004 Non-randomised trial.
Characteristics of studies awaiting assessment [ordered by study ID]
ATTEND pilot trial 2011
Methods RCT
Participants Stroke patients in hospital
Interventions Training and support for families
Outcomes 3-month outcomes
Notes Professor Jeyaraj Pandian, Ludhiana, Punjab, India
Edirne 2001
Methods RCT
Participants Stroke patients in hospital
Interventions In-patient versus community rehabilitation
Outcomes 2-month outcomes
Notes F Ozdemir, Trakya University School of Medicine, Edirne, Turkey
RCT: randomised controlled trial
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Characteristics of ongoing studies [ordered by study ID]
Aveiro
Trial name or title Aveiro
Methods RCT
Participants Acute stroke patients (World Health Organization definition), age 25 to 85 years, FIM < 100
Exclusion criteria: SAH, comorbidity, severe aphasia interfering seriously with the stroke rehabilitation, psy-
chological and psychiatric problems or other severe illness interfering seriously with the stroke rehabilitation
Interventions Community-based multidisciplinary team comprising physiotherapist, occupational therapist, gerontologist
(case manager) and psychologist - all staff with previous experience in stroke care but no specialized training
in stroke rehabilitation stroke care. Team co-ordinate and deliver care. Team are co-ordinated via weekly
multidisciplinary meetings
Outcomes Unclear at present
Starting date 6 September 2009
Contact information Silvina Santana
Notes
Bergen
Trial name or title Early supported discharge after stroke in Bergen
Methods Unclear at present
Participants Unclear at present
Interventions Unclear at present
Outcomes Unclear at present
Starting date December 2008
Contact information Dr J S Souken
Notes
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Hong Kong
Trial name or title Patient Engagement Program for Stroke (PEPS)
Methods Unclear at present
Participants Unclear at present
Interventions Unclear at present
Outcomes Unclear at present
Starting date May 2010
Contact information Dr Fung Pui Man
Notes Hong Kong
Perth
Trial name or title Establishing an effective and efficient early supported discharge rehabilitation program for stroke clients in
Perth (Western Australia)
Methods RCT
Participants Unclear at present
Interventions Unclear at present
Outcomes Unclear at present
Starting date 20 November 2011
Contact information Roslyn Jones
Notes Main ID: ACTRN12611001243909 (anzctr.org.au)
West Denmark
Trial name or title RCT
Computer-generated blocks of 10, opaque sealed envelopes
Methods 198 acute stroke patients in second line neurological rehabilitation units within 4 centres (Brönderslev,
Hammel, Ringe, Skive) screened on day 5 of admission
Participants Intervention: hospital out-reachmultidisciplinary teamcomprising physiotherapy, occupational therapy, nurs-
ing and speech and language therapy (in hospital only). Co-ordinate discharge planning, including pre-as-
sessment home visits and provide low-intensity rehabilitation (maximum 8 sessions) in the community for
a period of 1 month. Team are co-ordinated through twice weekly multidisciplinary meetings. Patients live
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West Denmark (Continued)
between 0 to 70 km (average 30 km) of team base
Control: conventional discharge planning from neurological rehabilitation unit with 1 pre-assessment home
visit and after care including home care, physiotherapy clinic and further inpatient rehabilitation if required
Interventions Outomces at 6 months: FIM, Frenchay activity index, EUROQOL
Mortality, institutionalisation, care requirements
Patient and carer satisfaction
Outcomes Unpublished information from authors
Starting date 2009
Contact information Birgitte G Jepson, Poul Mogensen
Notes
EUROQOL: European Quality of Life instrument
FIM: functional independence measure
RCT: randomised controlled trial
SAH: subarachnoid haemorrhage
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D A T A A N D A N A L Y S E S
Comparison 1. Early supported discharge service versus conventional care: patient outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 14 1957 Odds Ratio (M-H, Fixed, 95% CI) 0.91 [0.67, 1.25]
1.1 ESD team co-ordination
and delivery
9 1140 Odds Ratio (M-H, Fixed, 95% CI) 0.69 [0.44, 1.07]
1.2 ESD team co-ordination 3 464 Odds Ratio (M-H, Fixed, 95% CI) 0.95 [0.52, 1.74]
1.3 No ESD team 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.90 [0.90, 3.98]
2 Death or requiring institutional
care
12 1758 Odds Ratio (M-H, Fixed, 95% CI) 0.78 [0.61, 1.00]
2.1 ESD team co-ordination
and delivery
7 941 Odds Ratio (M-H, Fixed, 95% CI) 0.65 [0.45, 0.93]
2.2 ESD team co-ordination 3 464 Odds Ratio (M-H, Fixed, 95% CI) 0.75 [0.50, 1.14]
2.3 No ESD team 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.32 [0.75, 2.33]
3 Death or dependency 14 1957 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.67, 0.97]
3.1 ESD team co-ordination
and delivery
9 1140 Odds Ratio (M-H, Fixed, 95% CI) 0.71 [0.55, 0.91]
3.2 ESD team co-ordination 3 464 Odds Ratio (M-H, Fixed, 95% CI) 0.77 [0.54, 1.11]
3.3 No ESD team 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.23 [0.79, 1.91]
4 Activities of daily living (Barthel
ADL) score
9 1124 Std. Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.08, 0.15]
4.1 ESD team co-ordination
and delivery
7 825 Std. Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.08, 0.20]
4.2 ESD team co-ordination 1 48 Std. Mean Difference (IV, Fixed, 95% CI) -0.23 [-0.79, 0.34]
4.3 No ESD team 1 251 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.25, 0.25]
5 Extended activities of daily living
(EADL) score
9 1051 Std. Mean Difference (IV, Fixed, 95% CI) 0.14 [0.02, 0.26]
5.1 ESD team co-ordination
and delivery
7 729 Std. Mean Difference (IV, Fixed, 95% CI) 0.17 [0.02, 0.32]
5.2 ESD team co-ordination 2 322 Std. Mean Difference (IV, Fixed, 95% CI) 0.07 [-0.15, 0.29]
5.3 No ESD team 0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Subjective health status 12 1377 Std. Mean Difference (IV, Fixed, 95% CI) 0.00 [-0.10, 0.11]
6.1 ESD team co-ordination
and delivery
8 860 Std. Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.21, 0.06]
6.2 ESD team co-ordination 3 370 Std. Mean Difference (IV, Fixed, 95% CI) 0.14 [-0.07, 0.34]
6.3 No ESD team 1 147 Std. Mean Difference (IV, Fixed, 95% CI) 0.14 [-0.19, 0.47]
7 Mood status 8 851 Std. Mean Difference (IV, Fixed, 95% CI) -0.06 [-0.19, 0.07]
7.1 ESD team co-ordination
and delivery
5 383 Std. Mean Difference (IV, Fixed, 95% CI) -0.02 [-0.22, 0.18]
7.2 ESD team co-ordination 2 321 Std. Mean Difference (IV, Fixed, 95% CI) -0.08 [-0.30, 0.14]
7.3 No ESD team 1 147 Std. Mean Difference (IV, Fixed, 95% CI) -0.12 [-0.45, 0.20]
8 Satisfaction with services 5 513 Odds Ratio (M-H, Fixed, 95% CI) 1.60 [1.08, 2.38]
8.1 ESD team co-ordination
and delivery
4 450 Odds Ratio (M-H, Fixed, 95% CI) 1.74 [1.13, 2.67]
8.2 ESD team co-ordination 1 63 Odds Ratio (M-H, Fixed, 95% CI) 1.01 [0.36, 2.83]
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8.3 No ESD team 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Early supported discharge service versus conventional care: duration of follow-up
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death: within 6 months 9 1177 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.48, 1.34]
2 Death or dependency: within 6
months
9 1177 Odds Ratio (M-H, Fixed, 95% CI) 0.68 [0.53, 0.87]
3 Death: within 1 year 8 1381 Odds Ratio (M-H, Fixed, 95% CI) 0.91 [0.66, 1.26]
4 Death or dependency: within 1
year
7 1183 Odds Ratio (M-H, Fixed, 95% CI) 0.84 [0.66, 1.05]
5 Death: within 5 years 2 403 Odds Ratio (M-H, Fixed, 95% CI) 0.81 [0.54, 1.21]
6 Death or dependency: within 5
years
2 403 Odds Ratio (M-H, Fixed, 95% CI) 0.78 [0.52, 1.17]
Comparison 3. Early supported discharge service versus conventional care: carer outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Subjective health status 8 749 Std. Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.17, 0.12]
1.1 ESD team co-ordination
and delivery
5 373 Std. Mean Difference (IV, Fixed, 95% CI) -0.15 [-0.35, 0.06]
1.2 ESD team co-ordination 3 376 Std. Mean Difference (IV, Fixed, 95% CI) 0.09 [-0.12, 0.29]
1.3 No ESD team 0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Mood status 2 58 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-1.60, 1.22]
2.1 ESD team co-ordination
and delivery
2 58 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-1.60, 1.22]
2.2 ESD team co-ordination 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 No ESD team 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
3 Satisfaction with services 4 279 Odds Ratio (M-H, Fixed, 95% CI) 1.56 [0.87, 2.81]
3.1 ESD team co-ordination
and delivery
3 246 Odds Ratio (M-H, Fixed, 95% CI) 1.60 [0.85, 3.01]
3.2 ESD team co-ordination 1 33 Odds Ratio (M-H, Fixed, 95% CI) 1.28 [0.24, 6.70]
3.3 No ESD team 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 4. Early supported discharge service versus conventional care: resource use
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of initial hospital stay
(days)
13 1695 Mean Difference (IV, Random, 95% CI) -7.10 [-10.03, -4.17]
1.1 ESD team co-ordination
and delivery
9 1129 Mean Difference (IV, Random, 95% CI) -6.84 [-11.20, -2.49]
1.2 ESD team co-ordination 3 464 Mean Difference (IV, Random, 95% CI) -10.36 [-15.39, -5.
33]
1.3 No ESD team 1 102 Mean Difference (IV, Random, 95% CI) -7.0 [-8.61, -5.39]
2 Readmission to hospital 7 918 Odds Ratio (M-H, Fixed, 95% CI) 1.26 [0.94, 1.67]
2.1 ESD team co-ordination
and delivery
7 918 Odds Ratio (M-H, Fixed, 95% CI) 1.26 [0.94, 1.67]
2.2 ESD team co-ordination 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 No ESD team 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 5. Early supported discharge service versus conventional care: age subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 9 1175 Odds Ratio (M-H, Fixed, 95% CI) 0.85 [0.67, 1.08]
1.1 Age < 75 years 9 695 Odds Ratio (M-H, Fixed, 95% CI) 0.82 [0.60, 1.12]
1.2 Age > 75 years 9 480 Odds Ratio (M-H, Fixed, 95% CI) 0.90 [0.61, 1.31]
2 Length of stay (days) 8 911 Mean Difference (IV, Random, 95% CI) -9.69 [-13.56, -5.82]
2.1 Age < 75 years 8 566 Mean Difference (IV, Random, 95% CI) -11.68 [-18.00, -5.
36]
2.2 Age > 75 years 7 345 Mean Difference (IV, Random, 95% CI) -6.26 [-10.51, -2.01]
Comparison 6. Early supported discharge service versus conventional care: gender subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 9 1175 Odds Ratio (M-H, Fixed, 95% CI) 0.83 [0.65, 1.05]
1.1 Male 9 654 Odds Ratio (M-H, Fixed, 95% CI) 0.73 [0.54, 1.01]
1.2 Female 9 521 Odds Ratio (M-H, Fixed, 95% CI) 0.98 [0.68, 1.40]
2 Length of stay (days) 8 909 Mean Difference (IV, Fixed, 95% CI) -4.54 [-6.48, -2.60]
2.1 Male 8 518 Mean Difference (IV, Fixed, 95% CI) -4.32 [-6.65, -1.98]
2.2 Female 7 391 Mean Difference (IV, Fixed, 95% CI) -5.05 [-8.55, -1.55]
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Comparison 7. Early supported discharge service versus conventional care: stroke severity subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 11 1545 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.69, 1.07]
1.1 Initial Barthel 10 to 20 11 1164 Odds Ratio (M-H, Fixed, 95% CI) 0.77 [0.61, 0.98]
1.2 Initial Barthel < 10 10 381 Odds Ratio (M-H, Fixed, 95% CI) 1.40 [0.83, 2.36]
2 Length of stay (days) 9 960 Mean Difference (IV, Random, 95% CI) -7.33 [-12.15, -2.50]
2.1 Initial Barthel 10 to 20 9 788 Mean Difference (IV, Random, 95% CI) -3.11 [-7.13, 0.92]
2.2 Initial Barthel < 10 7 172 Mean Difference (IV, Random, 95% CI) -28.32 [-39.93, -16.
71]
Comparison 8. Early supported discharge service versus conventional care: carer subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 10 1237 Odds Ratio (M-H, Fixed, 95% CI) 0.87 [0.69, 1.10]
1.1 Carer present 10 799 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.64, 1.14]
1.2 No carer 9 438 Odds Ratio (M-H, Fixed, 95% CI) 0.90 [0.61, 1.32]
2 Length of stay (days) 9 970 Mean Difference (IV, Random, 95% CI) -7.96 [-12.01, -3.92]
2.1 Carer present 9 636 Mean Difference (IV, Random, 95% CI) -9.70 [-16.06, -3.33]
2.2 No carer 8 334 Mean Difference (IV, Random, 95% CI) -6.17 [-9.00, -1.34]
Comparison 9. Early supported discharge service versus conventional care: ESD service subgroups: service base
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 12 1604 Odds Ratio (M-H, Fixed, 95% CI) 0.73 [0.59, 0.90]
1.1 Community in-reach 6 755 Odds Ratio (M-H, Fixed, 95% CI) 0.72 [0.53, 0.96]
1.2 Hospital out-reach 6 849 Odds Ratio (M-H, Fixed, 95% CI) 0.74 [0.56, 1.00]
2 Length of stay (days) 11 1395 Mean Difference (IV, Random, 95% CI) -7.86 [-11.99, -3.73]
2.1 Community in-reach 6 744 Mean Difference (IV, Random, 95% CI) -4.34 [-7.34, -1.34]
2.2 Hospital out-reach 5 651 Mean Difference (IV, Random, 95% CI) -9.62 [-17.88, -1.36]
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Comparison 10. Early supported discharge service versus conventional care: ESD service subgroups: MDT co-
ordination
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 14 1957 Odds Ratio (M-H, Fixed, 95% CI) 0.91 [0.67, 1.25]
1.1 MDT co-ordination 12 1604 Odds Ratio (M-H, Fixed, 95% CI) 0.77 [0.54, 1.09]
1.2 No MDT 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.90 [0.90, 3.98]
2 Death or requiring institutional
care
12 1758 Odds Ratio (M-H, Fixed, 95% CI) 0.78 [0.61, 1.00]
2.1 MDT co-ordination 10 1405 Odds Ratio (M-H, Fixed, 95% CI) 0.69 [0.53, 0.91]
2.2 No MDT 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.32 [0.75, 2.33]
3 Death or dependency 14 1957 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.67, 0.97]
3.1 MDT co-ordination 12 1604 Odds Ratio (M-H, Fixed, 95% CI) 0.73 [0.59, 0.90]
3.2 No MDT 2 353 Odds Ratio (M-H, Fixed, 95% CI) 1.23 [0.79, 1.91]
4 Length of stay (days) 13 1695 Mean Difference (IV, Random, 95% CI) -7.21 [-10.12, -4.30]
4.1 MDT co-ordination 12 1593 Mean Difference (IV, Random, 95% CI) -7.62 [-11.39, -3.86]
4.2 No MDT 1 102 Mean Difference (IV, Random, 95% CI) -7.0 [-8.61, -5.39]
Comparison 11. Early supported discharge service versus conventional care: conventional service subgroups
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death or dependency 14 1957 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.67, 0.97]
1.1 Stroke unit 9 1115 Odds Ratio (M-H, Fixed, 95% CI) 0.83 [0.66, 1.06]
1.2 Other wards 7 842 Odds Ratio (M-H, Fixed, 95% CI) 0.76 [0.56, 1.02]
2 Length of stay (days) 12 1517 Mean Difference (IV, Random, 95% CI) -7.28 [-10.64, -3.93]
2.1 Stroke unit 9 882 Mean Difference (IV, Random, 95% CI) -6.37 [-12.76, 0.02]
2.2 Other wards 6 635 Mean Difference (IV, Random, 95% CI) -7.25 [-11.47, -3.03]
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Analysis 1.1. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 1 Death.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 1 Death
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 2/42 0/44 0.6 % 5.49 [ 0.26, 117.88 ]
Belfast 2004 1/59 3/54 3.8 % 0.29 [ 0.03, 2.91 ]
Copenhagen 2009 0/50 3/50 4.3 % 0.13 [ 0.01, 2.67 ]
Glostrup 2006 3/103 3/95 3.8 % 0.92 [ 0.18, 4.67 ]
London 1999 26/167 34/164 36.2 % 0.71 [ 0.40, 1.24 ]
Manchester 2001 1/12 2/11 2.4 % 0.41 [ 0.03, 5.28 ]
Montreal 2000 2/58 0/56 0.6 % 5.00 [ 0.23, 106.50 ]
Newcastle 1997 2/46 4/46 4.8 % 0.48 [ 0.08, 2.74 ]
Stockholm 1998 1/42 3/41 3.7 % 0.31 [ 0.03, 3.10 ]
Subtotal (95% CI) 579 561 60.2 % 0.69 [ 0.44, 1.07 ]
Total events: 38 (Treatment), 52 (Control)
Heterogeneity: Chi2 = 5.98, df = 8 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.68 (P = 0.094)
2 ESD team co-ordination
Oslo 2000 2/42 4/40 4.9 % 0.45 [ 0.08, 2.61 ]
Trondheim 2000 13/160 15/160 17.2 % 0.85 [ 0.39, 1.86 ]
Trondheim 2004 8/31 5/31 4.6 % 1.81 [ 0.52, 6.31 ]
Subtotal (95% CI) 233 231 26.7 % 0.95 [ 0.52, 1.74 ]
Total events: 23 (Treatment), 24 (Control)
Heterogeneity: Chi2 = 1.79, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.18 (P = 0.86)
3 No ESD team
Akershus 1998 20/124 12/127 12.4 % 1.84 [ 0.86, 3.95 ]
Bangkok 2002 1/52 0/50 0.6 % 2.94 [ 0.12, 73.93 ]
Subtotal (95% CI) 176 177 13.0 % 1.90 [ 0.90, 3.98 ]
Total events: 21 (Treatment), 12 (Control)
Heterogeneity: Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.091)
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(. . . Continued)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 988 969 100.0 % 0.91 [ 0.67, 1.25 ]
Total events: 82 (Treatment), 88 (Control)
Heterogeneity: Chi2 = 13.15, df = 13 (P = 0.44); I2 =1%
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Chi2 = 5.35, df = 2 (P = 0.07), I2 =63%
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Analysis 1.2. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 2 Death or requiring institutional care.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 2 Death or requiring institutional care
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Copenhagen 2009 8/50 12/50 7.0 % 0.60 [ 0.22, 1.63 ]
Glostrup 2006 7/103 3/95 2.0 % 2.24 [ 0.56, 8.91 ]
London 1999 41/167 55/164 28.9 % 0.64 [ 0.40, 1.04 ]
Manchester 2001 2/12 3/11 1.8 % 0.53 [ 0.07, 4.01 ]
Montreal 2000 2/58 4/56 2.7 % 0.46 [ 0.08, 2.64 ]
Newcastle 1997 4/46 9/46 5.7 % 0.39 [ 0.11, 1.38 ]
Stockholm 1998 1/42 3/41 2.0 % 0.31 [ 0.03, 3.10 ]
Subtotal (95% CI) 478 463 50.1 % 0.65 [ 0.45, 0.93 ]
Total events: 65 (Treatment), 89 (Control)
Heterogeneity: Chi2 = 4.29, df = 6 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 2.35 (P = 0.019)
2 ESD team co-ordination
Oslo 2000 10/42 15/40 8.1 % 0.52 [ 0.20, 1.35 ]
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(. . . Continued)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Trondheim 2000 34/160 43/160 23.4 % 0.73 [ 0.44, 1.23 ]
Trondheim 2004 11/31 9/31 4.0 % 1.34 [ 0.46, 3.92 ]
Subtotal (95% CI) 233 231 35.5 % 0.75 [ 0.50, 1.14 ]
Total events: 55 (Treatment), 67 (Control)
Heterogeneity: Chi2 = 1.71, df = 2 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.33 (P = 0.18)
3 No ESD team
Akershus 1998 33/124 28/127 14.0 % 1.28 [ 0.72, 2.29 ]
Bangkok 2002 1/52 0/50 0.3 % 2.94 [ 0.12, 73.93 ]
Subtotal (95% CI) 176 177 14.4 % 1.32 [ 0.75, 2.33 ]
Total events: 34 (Treatment), 28 (Control)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Total (95% CI) 887 871 100.0 % 0.78 [ 0.61, 1.00 ]
Total events: 154 (Treatment), 184 (Control)
Heterogeneity: Chi2 = 10.57, df = 11 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 1.97 (P = 0.049)
Test for subgroup differences: Chi2 = 4.36, df = 2 (P = 0.11), I2 =54%
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Analysis 1.3. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 3 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 3 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 13/42 16/44 4.4 % 0.78 [ 0.32, 1.92 ]
Belfast 2004 29/59 32/54 6.9 % 0.66 [ 0.32, 1.40 ]
Copenhagen 2009 17/50 25/50 6.7 % 0.52 [ 0.23, 1.15 ]
Glostrup 2006 18/103 17/95 5.9 % 0.97 [ 0.47, 2.02 ]
London 1999 105/167 109/164 16.6 % 0.85 [ 0.54, 1.34 ]
Manchester 2001 5/12 7/11 1.7 % 0.41 [ 0.08, 2.19 ]
Montreal 2000 17/58 24/56 7.0 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 22/46 28/46 5.9 % 0.59 [ 0.26, 1.35 ]
Stockholm 1998 9/42 12/41 3.9 % 0.66 [ 0.24, 1.79 ]
Subtotal (95% CI) 579 561 59.1 % 0.71 [ 0.55, 0.91 ]
Total events: 235 (Treatment), 270 (Control)
Heterogeneity: Chi2 = 3.08, df = 8 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 2.66 (P = 0.0078)
2 ESD team co-ordination
Oslo 2000 16/42 17/40 4.4 % 0.83 [ 0.34, 2.01 ]
Trondheim 2000 64/160 81/160 19.7 % 0.65 [ 0.42, 1.01 ]
Trondheim 2004 19/31 15/31 2.4 % 1.69 [ 0.62, 4.63 ]
Subtotal (95% CI) 233 231 26.5 % 0.77 [ 0.54, 1.11 ]
Total events: 99 (Treatment), 113 (Control)
Heterogeneity: Chi2 = 2.92, df = 2 (P = 0.23); I2 =31%
Test for overall effect: Z = 1.38 (P = 0.17)
3 No ESD team
Akershus 1998 70/124 61/127 10.7 % 1.40 [ 0.85, 2.31 ]
Bangkok 2002 9/52 11/50 3.8 % 0.74 [ 0.28, 1.98 ]
Subtotal (95% CI) 176 177 14.4 % 1.23 [ 0.79, 1.91 ]
Total events: 79 (Treatment), 72 (Control)
Heterogeneity: Chi2 = 1.29, df = 1 (P = 0.26); I2 =22%
Test for overall effect: Z = 0.92 (P = 0.36)
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(. . . Continued)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 988 969 100.0 % 0.80 [ 0.67, 0.97 ]
Total events: 413 (Treatment), 455 (Control)
Heterogeneity: Chi2 = 11.77, df = 13 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Chi2 = 4.51, df = 2 (P = 0.10), I2 =56%
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Analysis 1.4. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 4 Activities of daily living (Barthel ADL) score.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 4 Activities of daily living (Barthel ADL) score
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 42 96 (9) 44 98 (10) 7.6 % -0.21 [ -0.63, 0.22 ]
Belfast 2004 56 17.68 (3.05) 48 16.94 (3.94) 9.2 % 0.21 [ -0.18, 0.60 ]
Copenhagen 2009 43 19.5 (5) 44 19 (3) 7.8 % 0.12 [ -0.30, 0.54 ]
Glostrup 2006 90 89.9 (20) 88 88.8 (20) 15.9 % 0.05 [ -0.24, 0.35 ]
London 1999 136 16 (4) 126 16 (4) 23.4 % 0.0 [ -0.24, 0.24 ]
Manchester 2001 9 17 (4) 8 15 (7) 1.5 % 0.34 [ -0.62, 1.30 ]
Montreal 2000 48 97.1 (6.9) 43 95.1 (10.6) 8.0 % 0.22 [ -0.19, 0.64 ]
Subtotal (95% CI) 424 401 73.3 % 0.06 [ -0.08, 0.20 ]
Heterogeneity: Chi2 = 3.37, df = 6 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.38)
2 ESD team co-ordination
Trondheim 2004 23 71.7 (34.7) 25 79 (28.7) 4.2 % -0.23 [ -0.79, 0.34 ]
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Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Subtotal (95% CI) 23 25 4.2 % -0.23 [ -0.79, 0.34 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.43)
3 No ESD team
Akershus 1998 124 95 (20) 127 95 (20) 22.4 % 0.0 [ -0.25, 0.25 ]
Subtotal (95% CI) 124 127 22.4 % 0.0 [ -0.25, 0.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 571 553 100.0 % 0.03 [ -0.08, 0.15 ]
Heterogeneity: Chi2 = 4.39, df = 8 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Chi2 = 1.03, df = 2 (P = 0.60), I2 =0.0%
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Analysis 1.5. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 5 Extended activities of daily living (EADL) score.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 5 Extended activities of daily living (EADL) score
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 42 39.7 (32.5) 44 36.4 (37.8) 8.2 % 0.09 [ -0.33, 0.52 ]
Belfast 2004 56 11.66 (5.8) 48 10.21 (6.34) 9.8 % 0.24 [ -0.15, 0.62 ]
London 1999 136 27 (12) 126 27 (11) 25.1 % 0.0 [ -0.24, 0.24 ]
Manchester 2001 9 12 (6) 8 9 (6) 1.6 % 0.47 [ -0.50, 1.44 ]
Montreal 2000 51 11 (3.5) 44 9.5 (3.9) 8.9 % 0.40 [ 0.00, 0.81 ]
Newcastle 1997 45 10 (13) 42 7 (15) 8.3 % 0.21 [ -0.21, 0.63 ]
Stockholm 1998 40 24 (6) 38 21.5 (8) 7.4 % 0.35 [ -0.10, 0.80 ]
Subtotal (95% CI) 379 350 69.2 % 0.17 [ 0.02, 0.32 ]
Heterogeneity: Chi2 = 4.44, df = 6 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.28 (P = 0.022)
2 ESD team co-ordination
Oslo 2000 34 35.35 (13.46) 31 35.81 (16.51) 6.2 % -0.03 [ -0.52, 0.46 ]
Trondheim 2000 133 32.2 (11.1) 124 31.1 (11.1) 24.6 % 0.10 [ -0.15, 0.34 ]
Subtotal (95% CI) 167 155 30.8 % 0.07 [ -0.15, 0.29 ]
Heterogeneity: Chi2 = 0.22, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.65 (P = 0.51)
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 546 505 100.0 % 0.14 [ 0.02, 0.26 ]
Heterogeneity: Chi2 = 5.18, df = 8 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.26 (P = 0.024)
Test for subgroup differences: Chi2 = 0.53, df = 1 (P = 0.47), I2 =0.0%
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Analysis 1.6. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 6 Subjective health status.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 6 Subjective health status
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 42 61.8 (26.5) 44 67.3 (21.9) 6.2 % -0.22 [ -0.65, 0.20 ]
Belfast 2004 56 66.14 (21) 47 68.45 (20.95) 7.5 % -0.11 [ -0.50, 0.28 ]
Glostrup 2006 89 38.9 (10) 86 37.9 (10.29) 12.8 % 0.10 [ -0.20, 0.39 ]
London 1999 118 31 (9) 105 33 (8) 16.2 % -0.23 [ -0.50, 0.03 ]
Manchester 2001 9 64 (14) 8 63 (20) 1.2 % 0.06 [ -0.90, 1.01 ]
Montreal 2000 47 63.5 (20.8) 44 56.7 (25) 6.6 % 0.29 [ -0.12, 0.71 ]
Newcastle 1997 45 2 (2.9) 42 2 (2.1) 6.4 % 0.0 [ -0.42, 0.42 ]
Stockholm 1998 40 84 (11.36) 38 88.4 (13.71) 5.6 % -0.35 [ -0.79, 0.10 ]
Subtotal (95% CI) 446 414 62.5 % -0.07 [ -0.21, 0.06 ]
Heterogeneity: Chi2 = 7.87, df = 7 (P = 0.34); I2 =11%
Test for overall effect: Z = 1.09 (P = 0.27)
2 ESD team co-ordination
Oslo 2000 33 22.45 (8.04) 31 22.45 (8.77) 4.7 % 0.0 [ -0.49, 0.49 ]
Trondheim 2000 133 78.97 (17.52) 125 75.59 (17.06) 18.8 % 0.19 [ -0.05, 0.44 ]
Trondheim 2004 23 79.8 (16.8) 25 79.8 (17.7) 3.5 % 0.0 [ -0.57, 0.57 ]
Subtotal (95% CI) 189 181 27.0 % 0.14 [ -0.07, 0.34 ]
Heterogeneity: Chi2 = 0.74, df = 2 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
3 No ESD team
Akershus 1998 65 55 (22) 82 52 (21) 10.6 % 0.14 [ -0.19, 0.47 ]
Subtotal (95% CI) 65 82 10.6 % 0.14 [ -0.19, 0.47 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI) 700 677 100.0 % 0.00 [ -0.10, 0.11 ]
Heterogeneity: Chi2 = 12.20, df = 11 (P = 0.35); I2 =10%
Test for overall effect: Z = 0.08 (P = 0.93)
Test for subgroup differences: Chi2 = 3.59, df = 2 (P = 0.17), I2 =44%
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Analysis 1.7. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 7 Mood status.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 7 Mood status
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 42 80.5 (17.3) 44 82.6 (13.6) 10.1 % -0.13 [ -0.56, 0.29 ]
Belfast 2004 56 69.36 (21.43) 47 69.19 (18.65) 12.1 % 0.01 [ -0.38, 0.40 ]
Manchester 2001 8 15 (5) 8 12 (5) 1.8 % 0.57 [ -0.44, 1.57 ]
Montreal 2000 47 65.2 (20.8) 44 66.4 (19.2) 10.7 % -0.06 [ -0.47, 0.35 ]
Newcastle 1997 45 3 (2.9) 42 3 (2.9) 10.3 % 0.0 [ -0.42, 0.42 ]
Subtotal (95% CI) 198 185 45.0 % -0.02 [ -0.22, 0.18 ]
Heterogeneity: Chi2 = 1.65, df = 4 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
2 ESD team co-ordination
Oslo 2000 33 2.73 (3.18) 31 3.42 (3.47) 7.5 % -0.21 [ -0.70, 0.29 ]
Trondheim 2000 132 5.52 (5.83) 125 5.82 (6.34) 30.3 % -0.05 [ -0.29, 0.20 ]
Subtotal (95% CI) 165 156 37.9 % -0.08 [ -0.30, 0.14 ]
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
3 No ESD team
Akershus 1998 65 69 (15) 82 71 (17) 17.1 % -0.12 [ -0.45, 0.20 ]
Subtotal (95% CI) 65 82 17.1 % -0.12 [ -0.45, 0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
Total (95% CI) 428 423 100.0 % -0.06 [ -0.19, 0.07 ]
Heterogeneity: Chi2 = 2.30, df = 7 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Chi2 = 0.33, df = 2 (P = 0.85), I2 =0.0%
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Analysis 1.8. Comparison 1 Early supported discharge service versus conventional care: patient outcomes,
Outcome 8 Satisfaction with services.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 1 Early supported discharge service versus conventional care: patient outcomes
Outcome: 8 Satisfaction with services
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 37/42 32/44 9.5 % 2.78 [ 0.88, 8.73 ]
Belfast 2004 28/53 18/43 24.0 % 1.56 [ 0.69, 3.50 ]
London 1999 58/98 43/90 46.8 % 1.58 [ 0.89, 2.82 ]
Stockholm 1998 40/40 39/40 1.2 % 3.08 [ 0.12, 77.80 ]
Subtotal (95% CI) 233 217 81.5 % 1.74 [ 1.13, 2.67 ]
Total events: 163 (Treatment), 132 (Control)
Heterogeneity: Chi2 = 0.93, df = 3 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 2.52 (P = 0.012)
2 ESD team co-ordination
Oslo 2000 21/33 19/30 18.5 % 1.01 [ 0.36, 2.83 ]
Subtotal (95% CI) 33 30 18.5 % 1.01 [ 0.36, 2.83 ]
Total events: 21 (Treatment), 19 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Treatment), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 266 247 100.0 % 1.60 [ 1.08, 2.38 ]
Total events: 184 (Treatment), 151 (Control)
Heterogeneity: Chi2 = 1.81, df = 4 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Chi2 = 0.90, df = 1 (P = 0.34), I2 =0.0%
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Analysis 2.1. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 1 Death: within 6 months.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 1 Death: within 6 months
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adelaide 2000 2/42 0/44 1.4 % 5.49 [ 0.26, 117.88 ]
Bangkok 2002 1/52 0/50 1.5 % 2.94 [ 0.12, 73.93 ]
Copenhagen 2009 0/50 3/50 10.7 % 0.13 [ 0.01, 2.67 ]
Glostrup 2006 3/103 3/95 9.3 % 0.92 [ 0.18, 4.67 ]
Montreal 2000 2/58 0/56 1.5 % 5.00 [ 0.23, 106.50 ]
Newcastle 1997 2/46 4/46 11.8 % 0.48 [ 0.08, 2.74 ]
Oslo 2000 2/42 4/40 12.0 % 0.45 [ 0.08, 2.61 ]
Stockholm 1998 1/42 3/41 9.1 % 0.31 [ 0.03, 3.10 ]
Trondheim 2000 13/160 15/160 42.5 % 0.85 [ 0.39, 1.86 ]
Total (95% CI) 595 582 100.0 % 0.80 [ 0.48, 1.34 ]
Total events: 26 (Treatment), 32 (Control)
Heterogeneity: Chi2 = 6.35, df = 8 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 0.84 (P = 0.40)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 2 Death or dependency: within 6 months.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 2 Death or dependency: within 6 months
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adelaide 2000 13/42 16/44 7.1 % 0.78 [ 0.32, 1.92 ]
Bangkok 2002 9/52 11/50 6.1 % 0.74 [ 0.28, 1.98 ]
Copenhagen 2009 17/50 25/50 10.9 % 0.52 [ 0.23, 1.15 ]
Glostrup 2006 18/103 17/95 9.6 % 0.97 [ 0.47, 2.02 ]
Montreal 2000 17/58 24/56 11.4 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 22/46 28/46 9.6 % 0.59 [ 0.26, 1.35 ]
Oslo 2000 16/42 17/40 7.1 % 0.83 [ 0.34, 2.01 ]
Stockholm 1998 9/42 12/41 6.3 % 0.66 [ 0.24, 1.79 ]
Trondheim 2000 64/160 81/160 32.0 % 0.65 [ 0.42, 1.01 ]
Total (95% CI) 595 582 100.0 % 0.68 [ 0.53, 0.87 ]
Total events: 185 (Treatment), 231 (Control)
Heterogeneity: Chi2 = 2.13, df = 8 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 3.07 (P = 0.0021)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 3 Death: within 1 year.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 3 Death: within 1 year
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Akershus 1998 20/124 12/127 12.9 % 1.84 [ 0.86, 3.95 ]
Belfast 2004 1/59 3/54 4.0 % 0.29 [ 0.03, 2.91 ]
Glostrup 2006 5/103 4/95 5.1 % 1.16 [ 0.30, 4.46 ]
London 1999 26/167 34/164 37.6 % 0.71 [ 0.40, 1.24 ]
Manchester 2001 1/12 2/11 2.5 % 0.41 [ 0.03, 5.28 ]
Stockholm 1998 1/42 3/41 3.8 % 0.31 [ 0.03, 3.10 ]
Trondheim 2000 21/160 26/160 29.3 % 0.78 [ 0.42, 1.45 ]
Trondheim 2004 8/31 5/31 4.8 % 1.81 [ 0.52, 6.31 ]
Total (95% CI) 698 683 100.0 % 0.91 [ 0.66, 1.26 ]
Total events: 83 (Treatment), 89 (Control)
Heterogeneity: Chi2 = 7.75, df = 7 (P = 0.35); I2 =10%
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 4 Death or dependency: within 1 year.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 4 Death or dependency: within 1 year
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Akershus 1998 70/124 61/127 16.7 % 1.40 [ 0.85, 2.31 ]
Belfast 2004 29/59 32/54 10.8 % 0.66 [ 0.32, 1.40 ]
London 1999 105/167 109/164 25.9 % 0.85 [ 0.54, 1.34 ]
Manchester 2001 5/12 7/11 2.7 % 0.41 [ 0.08, 2.19 ]
Stockholm 1998 10/42 18/41 8.8 % 0.40 [ 0.16, 1.02 ]
Trondheim 2000 70/160 88/160 31.4 % 0.64 [ 0.41, 0.99 ]
Trondheim 2004 19/31 15/31 3.7 % 1.69 [ 0.62, 4.63 ]
Total (95% CI) 595 588 100.0 % 0.84 [ 0.66, 1.05 ]
Total events: 308 (Treatment), 330 (Control)
Heterogeneity: Chi2 = 10.94, df = 6 (P = 0.09); I2 =45%
Test for overall effect: Z = 1.53 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 5 Death: within 5 years.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 5 Death: within 5 years
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stockholm 1998 8/42 12/41 18.7 % 0.57 [ 0.20, 1.58 ]
Trondheim 2000 71/160 77/160 81.3 % 0.86 [ 0.55, 1.33 ]
Total (95% CI) 202 201 100.0 % 0.81 [ 0.54, 1.21 ]
Total events: 79 (Treatment), 89 (Control)
Heterogeneity: Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Early supported discharge service versus conventional care: duration of follow-
up, Outcome 6 Death or dependency: within 5 years.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 2 Early supported discharge service versus conventional care: duration of follow-up
Outcome: 6 Death or dependency: within 5 years
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stockholm 1998 18/42 22/41 24.2 % 0.65 [ 0.27, 1.54 ]
Trondheim 2000 101/160 108/160 75.8 % 0.82 [ 0.52, 1.31 ]
Total (95% CI) 202 201 100.0 % 0.78 [ 0.52, 1.17 ]
Total events: 119 (Treatment), 130 (Control)
Heterogeneity: Chi2 = 0.23, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Early supported discharge service versus conventional care: carer outcomes,
Outcome 1 Subjective health status.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 3 Early supported discharge service versus conventional care: carer outcomes
Outcome: 1 Subjective health status
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 24 67.9 (20) 25 63.5 (24.5) 6.6 % 0.19 [ -0.37, 0.75 ]
Belfast 2004 31 6.81 (3.29) 27 6.48 (4.27) 7.8 % 0.09 [ -0.43, 0.60 ]
London 1999 75 8 (4) 59 9 (3) 17.7 % -0.28 [ -0.62, 0.07 ]
Montreal 2000 49 16.4 (14.7) 42 21.7 (14.7) 12.0 % -0.36 [ -0.77, 0.06 ]
Newcastle 1997 22 25 (15) 19 25 (19) 5.5 % 0.0 [ -0.61, 0.61 ]
Subtotal (95% CI) 201 172 49.7 % -0.15 [ -0.35, 0.06 ]
Heterogeneity: Chi2 = 3.95, df = 4 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 1.40 (P = 0.16)
2 ESD team co-ordination
Oslo 2000 42 50.76 (22.29) 40 57.32 (17.18) 10.9 % -0.33 [ -0.76, 0.11 ]
Trondheim 2000 128 23.39 (2.7) 121 22.58 (3.12) 33.3 % 0.28 [ 0.03, 0.53 ]
Trondheim 2004 23 24.3 (2.7) 22 24.8 (1.9) 6.1 % -0.21 [ -0.80, 0.38 ]
Subtotal (95% CI) 193 183 50.3 % 0.09 [ -0.12, 0.29 ]
Heterogeneity: Chi2 = 6.65, df = 2 (P = 0.04); I2 =70%
Test for overall effect: Z = 0.85 (P = 0.40)
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 394 355 100.0 % -0.03 [ -0.17, 0.12 ]
Heterogeneity: Chi2 = 13.13, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 0.39 (P = 0.70)
Test for subgroup differences: Chi2 = 2.53, df = 1 (P = 0.11), I2 =60%
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Analysis 3.2. Comparison 3 Early supported discharge service versus conventional care: carer outcomes,
Outcome 2 Mood status.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 3 Early supported discharge service versus conventional care: carer outcomes
Outcome: 2 Mood status
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 24 69.6 (18.5) 25 82 (11.9) 59.5 % -0.79 [ -1.37, -0.20 ]
Manchester 2001 4 16 (4) 5 12 (6) 40.5 % 0.68 [ -0.70, 2.06 ]
Subtotal (95% CI) 28 30 100.0 % -0.19 [ -1.60, 1.22 ]
Heterogeneity: Tau2 = 0.78; Chi2 = 3.68, df = 1 (P = 0.05); I2 =73%
Test for overall effect: Z = 0.27 (P = 0.79)
2 ESD team co-ordination
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 28 30 100.0 % -0.19 [ -1.60, 1.22 ]
Heterogeneity: Tau2 = 0.78; Chi2 = 3.68, df = 1 (P = 0.05); I2 =73%
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Early supported discharge service versus conventional care: carer outcomes,
Outcome 3 Satisfaction with services.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 3 Early supported discharge service versus conventional care: carer outcomes
Outcome: 3 Satisfaction with services
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 17/24 13/25 21.1 % 2.24 [ 0.69, 7.29 ]
Belfast 2004 25/27 19/25 8.3 % 3.95 [ 0.72, 21.78 ]
London 1999 68/82 52/63 56.9 % 1.03 [ 0.43, 2.45 ]
Subtotal (95% CI) 133 113 86.3 % 1.60 [ 0.85, 3.01 ]
Total events: 110 (Treatment), 84 (Control)
Heterogeneity: Chi2 = 2.39, df = 2 (P = 0.30); I2 =16%
Test for overall effect: Z = 1.47 (P = 0.14)
2 ESD team co-ordination
Oslo 2000 17/22 8/11 13.7 % 1.28 [ 0.24, 6.70 ]
Subtotal (95% CI) 22 11 13.7 % 1.28 [ 0.24, 6.70 ]
Total events: 17 (Treatment), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Treatment), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 155 124 100.0 % 1.56 [ 0.87, 2.81 ]
Total events: 127 (Treatment), 92 (Control)
Heterogeneity: Chi2 = 2.44, df = 3 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.80), I2 =0.0%
0.02 0.1 1 10 50
Favours control Favours treatment
62Services for reducing duration of hospital care for acute stroke patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.1. Comparison 4 Early supported discharge service versus conventional care: resource use,
Outcome 1 Length of initial hospital stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 4 Early supported discharge service versus conventional care: resource use
Outcome: 1 Length of initial hospital stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 42 20.9 (20.55) 44 36 (24.04) 6.3 % -15.10 [ -24.54, -5.66 ]
Belfast 2004 59 41.9 (28.25) 54 49.5 (46.95) 3.3 % -7.60 [ -22.05, 6.85 ]
Copenhagen 2009 50 16.5 (10) 50 15 (16) 11.4 % 1.50 [ -3.73, 6.73 ]
Glostrup 2006 103 35.2 (30) 95 39.8 (30) 7.3 % -4.60 [ -12.96, 3.76 ]
London 1999 165 32.8 (33.05) 163 41.3 (40.09) 7.7 % -8.50 [ -16.46, -0.54 ]
Manchester 2001 10 39.8 (35.78) 11 46.09 (41.17) 0.8 % -6.29 [ -39.21, 26.63 ]
Montreal 2000 58 9.8 (5.3) 56 12 (7.07) 16.2 % -2.20 [ -4.50, 0.10 ]
Newcastle 1997 44 21.6 (24.59) 42 33.8 (35.22) 4.0 % -12.20 [ -25.09, 0.69 ]
Stockholm 1998 42 13.6 (6.93) 41 29.2 (26.28) 7.3 % -15.60 [ -23.91, -7.29 ]
Subtotal (95% CI) 573 556 64.3 % -6.84 [ -11.20, -2.49 ]
Heterogeneity: Tau2 = 22.77; Chi2 = 22.32, df = 8 (P = 0.004); I2 =64%
Test for overall effect: Z = 3.08 (P = 0.0021)
2 ESD team co-ordination
Oslo 2000 42 26.4 (17.33) 40 33.8 (21.83) 7.1 % -7.40 [ -15.96, 1.16 ]
Trondheim 2000 160 18.6 (30) 160 31.1 (30) 9.4 % -12.50 [ -19.07, -5.93 ]
Trondheim 2004 31 23.5 (30.5) 31 30.5 (44.8) 2.1 % -7.00 [ -26.08, 12.08 ]
Subtotal (95% CI) 233 231 18.6 % -10.36 [ -15.39, -5.33 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.99, df = 2 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 4.04 (P = 0.000054)
3 No ESD team
Bangkok 2002 52 3 (3) 50 10 (5) 17.1 % -7.00 [ -8.61, -5.39 ]
Subtotal (95% CI) 52 50 17.1 % -7.00 [ -8.61, -5.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.53 (P < 0.00001)
Total (95% CI) 858 837 100.0 % -7.10 [ -10.03, -4.17 ]
Heterogeneity: Tau2 = 12.38; Chi2 = 33.77, df = 12 (P = 0.00073); I2 =64%
Test for overall effect: Z = 4.76 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.59, df = 2 (P = 0.45), I2 =0.0%
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Analysis 4.2. Comparison 4 Early supported discharge service versus conventional care: resource use,
Outcome 2 Readmission to hospital.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 4 Early supported discharge service versus conventional care: resource use
Outcome: 2 Readmission to hospital
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 ESD team co-ordination and delivery
Adelaide 2000 15/42 11/44 8.3 % 1.67 [ 0.66, 4.22 ]
Belfast 2004 6/21 6/22 5.1 % 1.07 [ 0.28, 4.04 ]
Copenhagen 2009 12/43 13/44 11.2 % 0.92 [ 0.36, 2.34 ]
Glostrup 2006 57/103 39/95 21.9 % 1.78 [ 1.01, 3.13 ]
London 1999 44/167 42/164 37.7 % 1.04 [ 0.64, 1.70 ]
Newcastle 1997 5/46 5/46 5.4 % 1.00 [ 0.27, 3.72 ]
Stockholm 1998 16/41 14/40 10.4 % 1.19 [ 0.48, 2.93 ]
Subtotal (95% CI) 463 455 100.0 % 1.26 [ 0.94, 1.67 ]
Total events: 155 (Treatment), 130 (Control)
Heterogeneity: Chi2 = 3.00, df = 6 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
2 ESD team co-ordination
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Treatment), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 No ESD team
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Treatment), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 463 455 100.0 % 1.26 [ 0.94, 1.67 ]
Total events: 155 (Treatment), 130 (Control)
Heterogeneity: Chi2 = 3.00, df = 6 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Early supported discharge service versus conventional care: age subgroups,
Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 5 Early supported discharge service versus conventional care: age subgroups
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Age < 75 years
Adelaide 2000 7/27 9/27 0.70 [ 0.22, 2.27 ]
Akershus 1998 28/59 24/65 1.54 [ 0.75, 3.16 ]
Belfast 2004 18/40 21/38 0.66 [ 0.27, 1.62 ]
London 1999 63/115 58/95 0.77 [ 0.44, 1.34 ]
Manchester 2001 4/12 5/9 0.40 [ 0.07, 2.37 ]
Montreal 2000 9/34 10/34 0.86 [ 0.30, 2.50 ]
Newcastle 1997 12/26 15/29 0.80 [ 0.28, 2.31 ]
Oslo 2000 3/15 5/12 0.35 [ 0.06, 1.93 ]
Stockholm 1998 6/32 7/26 0.63 [ 0.18, 2.17 ]
Subtotal (95% CI) 360 335 0.82 [ 0.60, 1.12 ]
Total events: 150 (Treatment), 154 (Control)
Heterogeneity: Chi2 = 5.09, df = 8 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
2 Age > 75 years
Adelaide 2000 6/15 7/17 0.95 [ 0.23, 3.92 ]
Akershus 1998 42/65 37/62 1.23 [ 0.60, 2.53 ]
Belfast 2004 11/19 11/16 0.63 [ 0.15, 2.52 ]
London 1999 41/51 51/69 1.45 [ 0.60, 3.47 ]
Manchester 2001 1/1 2/2 0.0 [ 0.0, 0.0 ]
Montreal 2000 8/24 14/22 0.29 [ 0.08, 0.96 ]
Newcastle 1997 10/20 13/17 0.31 [ 0.07, 1.28 ]
Oslo 2000 13/27 12/28 1.24 [ 0.43, 3.58 ]
Stockholm 1998 3/10 5/15 0.86 [ 0.15, 4.82 ]
Subtotal (95% CI) 232 248 0.90 [ 0.61, 1.31 ]
Total events: 135 (Treatment), 152 (Control)
Heterogeneity: Chi2 = 8.11, df = 7 (P = 0.32); I2 =14%
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Study or subgroup Treatment Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 592 583 0.85 [ 0.67, 1.08 ]
Total events: 285 (Treatment), 306 (Control)
Heterogeneity: Chi2 = 13.34, df = 16 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Chi2 = 0.13, df = 1 (P = 0.72), I2 =0.0%
0.05 0.2 1 5 20
Favours treatment Favours control
Analysis 5.2. Comparison 5 Early supported discharge service versus conventional care: age subgroups,
Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 5 Early supported discharge service versus conventional care: age subgroups
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Age < 75 years
Adelaide 2000 27 22 (20) 27 36 (21) 6.8 % -14.00 [ -24.94, -3.06 ]
Belfast 2004 40 42 (23) 38 54 (33) 5.7 % -12.00 [ -24.68, 0.68 ]
London 1999 114 33 (32) 94 42 (33) 8.3 % -9.00 [ -17.89, -0.11 ]
Manchester 2001 10 33 (26) 9 46 (32) 1.9 % -13.00 [ -39.40, 13.40 ]
Montreal 2000 34 9.7 (7) 34 11.8 (9) 12.9 % -2.10 [ -5.93, 1.73 ]
Newcastle 1997 26 21 (19) 28 32 (25) 6.2 % -11.00 [ -22.79, 0.79 ]
Oslo 2000 15 23 (12) 12 41 (26) 4.2 % -18.00 [ -33.91, -2.09 ]
Stockholm 1998 32 14 (5) 26 34 (18) 9.9 % -20.00 [ -27.13, -12.87 ]
Subtotal (95% CI) 298 268 55.9 % -11.68 [ -18.00, -5.36 ]
Heterogeneity: Tau2 = 50.12; Chi2 = 23.46, df = 7 (P = 0.001); I2 =70%
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 3.62 (P = 0.00029)
2 Age > 75 years
Adelaide 2000 15 19 (16) 17 37 (27) 4.5 % -18.00 [ -33.18, -2.82 ]
Belfast 2004 19 42 (26) 16 55 (48) 1.9 % -13.00 [ -39.26, 13.26 ]
London 1999 51 31 (27) 69 41 (44) 5.7 % -10.00 [ -22.76, 2.76 ]
Montreal 2000 24 10 (5.6) 22 12.5 (7.1) 13.0 % -2.50 [ -6.22, 1.22 ]
Newcastle 1997 18 22 (21) 14 40 (40) 2.4 % -18.00 [ -41.09, 5.09 ]
Oslo 2000 27 28 (17) 28 31 (17) 8.2 % -3.00 [ -11.99, 5.99 ]
Stockholm 1998 10 12 (5.7) 15 21 (16) 8.4 % -9.00 [ -17.83, -0.17 ]
Subtotal (95% CI) 164 181 44.1 % -6.26 [ -10.51, -2.01 ]
Heterogeneity: Tau2 = 7.11; Chi2 = 7.66, df = 6 (P = 0.26); I2 =22%
Test for overall effect: Z = 2.89 (P = 0.0039)
Total (95% CI) 462 449 100.0 % -9.69 [ -13.56, -5.82 ]
Heterogeneity: Tau2 = 26.27; Chi2 = 33.47, df = 14 (P = 0.002); I2 =58%
Test for overall effect: Z = 4.91 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.95, df = 1 (P = 0.16), I2 =49%
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Analysis 6.1. Comparison 6 Early supported discharge service versus conventional care: gender subgroups,
Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 6 Early supported discharge service versus conventional care: gender subgroups
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Male
Adelaide 2000 10/26 10/22 4.4 % 0.75 [ 0.24, 2.37 ]
Akershus 1998 34/64 31/67 9.4 % 1.32 [ 0.66, 2.62 ]
Belfast 2004 11/32 17/30 7.7 % 0.40 [ 0.14, 1.12 ]
London 1999 51/92 58/93 17.1 % 0.75 [ 0.42, 1.35 ]
Manchester 2001 3/10 5/8 2.6 % 0.26 [ 0.04, 1.84 ]
Montreal 2000 11/37 15/40 6.7 % 0.71 [ 0.27, 1.83 ]
Newcastle 1997 12/26 14/24 5.2 % 0.61 [ 0.20, 1.88 ]
Oslo 2000 6/21 7/16 3.8 % 0.51 [ 0.13, 2.02 ]
Stockholm 1998 5/23 7/23 3.6 % 0.63 [ 0.17, 2.40 ]
Subtotal (95% CI) 331 323 60.6 % 0.73 [ 0.54, 1.01 ]
Total events: 143 (Treatment), 164 (Control)
Heterogeneity: Chi2 = 5.62, df = 8 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.054)
2 Female
Adelaide 2000 3/16 6/22 2.7 % 0.62 [ 0.13, 2.95 ]
Akershus 1998 36/60 30/60 8.0 % 1.50 [ 0.73, 3.09 ]
Belfast 2004 18/27 15/24 3.5 % 1.20 [ 0.38, 3.79 ]
London 1999 54/75 51/71 9.8 % 1.01 [ 0.49, 2.08 ]
Manchester 2001 2/2 2/3 0.2 % 3.00 [ 0.08, 115.34 ]
Montreal 2000 6/21 9/16 4.9 % 0.31 [ 0.08, 1.22 ]
Newcastle 1997 10/20 14/22 4.4 % 0.57 [ 0.17, 1.96 ]
Oslo 2000 10/21 10/24 3.2 % 1.27 [ 0.39, 4.14 ]
Stockholm 1998 4/19 5/18 2.7 % 0.69 [ 0.15, 3.14 ]
Subtotal (95% CI) 261 260 39.4 % 0.98 [ 0.68, 1.40 ]
Total events: 143 (Treatment), 142 (Control)
Heterogeneity: Chi2 = 5.98, df = 8 (P = 0.65); I2 =0.0%
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Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.14 (P = 0.89)
Total (95% CI) 592 583 100.0 % 0.83 [ 0.65, 1.05 ]
Total events: 286 (Treatment), 306 (Control)
Heterogeneity: Chi2 = 12.94, df = 17 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Chi2 = 1.34, df = 1 (P = 0.25), I2 =25%
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Analysis 6.2. Comparison 6 Early supported discharge service versus conventional care: gender subgroups,
Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 6 Early supported discharge service versus conventional care: gender subgroups
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Male
Adelaide 2000 26 21.1 (22.98) 22 39.7 (25.1) 2.0 % -18.60 [ -32.31, -4.89 ]
Belfast 2004 32 34.9 (25.47) 30 41.1 (36.37) 1.5 % -6.20 [ -21.92, 9.52 ]
London 1999 91 28.7 (27.93) 92 36.2 (31.01) 5.2 % -7.50 [ -16.05, 1.05 ]
Manchester 2001 9 34.78 (34) 8 47.38 (39.57) 0.3 % -12.60 [ -47.89, 22.69 ]
Montreal 2000 37 9.3 (5.09) 40 11.5 (6.74) 53.5 % -2.20 [ -4.86, 0.46 ]
Newcastle 1997 25 19.6 (22.15) 23 30.3 (31.01) 1.6 % -10.70 [ -26.06, 4.66 ]
Oslo 2000 21 22.1 (14.69) 16 30 (19.62) 2.9 % -7.90 [ -19.38, 3.58 ]
Stockholm 1998 23 11.5 (6.22) 23 34.2 (30.7) 2.3 % -22.70 [ -35.50, -9.90 ]
Subtotal (95% CI) 264 254 69.2 % -4.32 [ -6.65, -1.98 ]
Heterogeneity: Chi2 = 16.37, df = 7 (P = 0.02); I2 =57%
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Test for overall effect: Z = 3.63 (P = 0.00029)
2 Female
Adelaide 2000 16 20.5 (16.54) 22 32.2 (22.89) 2.4 % -11.70 [ -24.24, 0.84 ]
Belfast 2004 27 50.3 (29.55) 24 60 (56.62) 0.6 % -9.70 [ -34.95, 15.55 ]
London 1999 74 37.9 (38.02) 71 47.8 (48.91) 1.8 % -9.90 [ -24.20, 4.40 ]
Montreal 2000 21 10.8 (5.7) 16 13.4 (7.91) 18.0 % -2.60 [ -7.18, 1.98 ]
Newcastle 1997 19 24.3 (27.88) 19 38.2 (40.17) 0.8 % -13.90 [ -35.89, 8.09 ]
Oslo 2000 21 30.7 (19.02) 24 36.4 (23.23) 2.5 % -5.70 [ -18.05, 6.65 ]
Stockholm 1998 19 16.1 (7.04) 18 22.8 (18.11) 4.7 % -6.70 [ -15.65, 2.25 ]
Subtotal (95% CI) 197 194 30.8 % -5.05 [ -8.55, -1.55 ]
Heterogeneity: Chi2 = 3.52, df = 6 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.83 (P = 0.0047)
Total (95% CI) 461 448 100.0 % -4.54 [ -6.48, -2.60 ]
Heterogeneity: Chi2 = 20.00, df = 14 (P = 0.13); I2 =30%
Test for overall effect: Z = 4.58 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
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Analysis 7.1. Comparison 7 Early supported discharge service versus conventional care: stroke severity
subgroups, Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 7 Early supported discharge service versus conventional care: stroke severity subgroups
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Initial Barthel 10 to 20
Adelaide 2000 11/39 13/40 0.82 [ 0.31, 2.13 ]
Akershus 1998 30/74 22/64 1.30 [ 0.65, 2.61 ]
Belfast 2004 21/51 22/43 0.67 [ 0.29, 1.51 ]
London 1999 55/116 71/120 0.62 [ 0.37, 1.04 ]
Manchester 2001 5/10 5/9 0.80 [ 0.13, 4.87 ]
Montreal 2000 17/58 23/55 0.58 [ 0.26, 1.26 ]
Newcastle 1997 10/34 12/29 0.59 [ 0.21, 1.68 ]
Oslo 2000 13/37 12/32 0.90 [ 0.34, 2.41 ]
Stockholm 1998 7/37 11/39 0.59 [ 0.20, 1.75 ]
Trondheim 2000 35/120 41/112 0.71 [ 0.41, 1.24 ]
Trondheim 2004 14/25 6/20 2.97 [ 0.86, 10.26 ]
Subtotal (95% CI) 601 563 0.77 [ 0.61, 0.98 ]
Total events: 218 (Treatment), 238 (Control)
Heterogeneity: Chi2 = 8.71, df = 10 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 2.10 (P = 0.036)
2 Initial Barthel < 10
Adelaide 2000 3/3 4/4 0.0 [ 0.0, 0.0 ]
Akershus 1998 40/50 39/63 2.46 [ 1.04, 5.81 ]
Belfast 2004 8/8 10/11 2.43 [ 0.09, 67.57 ]
London 1999 43/44 36/42 7.17 [ 0.82, 62.32 ]
Manchester 2001 0/2 2/2 0.04 [ 0.00, 2.93 ]
Newcastle 1997 12/12 14/15 2.59 [ 0.10, 69.34 ]
Oslo 2000 3/5 5/8 0.90 [ 0.09, 8.90 ]
Stockholm 1998 2/5 1/2 0.67 [ 0.02, 18.06 ]
Trondheim 2000 29/40 40/48 0.53 [ 0.19, 1.47 ]
Trondheim 2004 5/6 9/11 1.11 [ 0.08, 15.53 ]
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Study or subgroup Treatment Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 175 206 1.40 [ 0.83, 2.36 ]
Total events: 145 (Treatment), 160 (Control)
Heterogeneity: Chi2 = 10.55, df = 8 (P = 0.23); I2 =24%
Test for overall effect: Z = 1.26 (P = 0.21)
Total (95% CI) 776 769 0.86 [ 0.69, 1.07 ]
Total events: 363 (Treatment), 398 (Control)
Heterogeneity: Chi2 = 22.66, df = 19 (P = 0.25); I2 =16%
Test for overall effect: Z = 1.37 (P = 0.17)
Test for subgroup differences: Chi2 = 4.10, df = 1 (P = 0.04), I2 =76%
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Analysis 7.2. Comparison 7 Early supported discharge service versus conventional care: stroke severity
subgroups, Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 7 Early supported discharge service versus conventional care: stroke severity subgroups
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Initial Barthel 10 to 20
Adelaide 2000 39 21 (14) 40 33 (20) 9.3 % -12.00 [ -19.60, -4.40 ]
Belfast 2004 51 39 (29) 43 34 (32) 6.7 % 5.00 [ -7.44, 17.44 ]
London 1999 114 24 (28) 119 28 (26) 9.6 % -4.00 [ -10.95, 2.95 ]
Manchester 2001 9 35 (35) 9 35 (38) 1.7 % 0.0 [ -33.75, 33.75 ]
Montreal 2000 58 10 (5.6) 55 12.8 (6.5) 11.8 % -2.80 [ -5.04, -0.56 ]
Newcastle 1997 33 19 (17) 28 24 (23) 7.8 % -5.00 [ -15.31, 5.31 ]
Oslo 2000 37 24 (15) 32 26 (15) 9.6 % -2.00 [ -9.10, 5.10 ]
Stockholm 1998 37 13 (10) 39 25 (14) 10.5 % -12.00 [ -17.45, -6.55 ]
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Trondheim 2004 18 22.2 (25.1) 13 14.5 (13.7) 6.1 % 7.70 [ -6.08, 21.48 ]
Trondheim 2004 7 10.3 (11.3) 7 2.6 (1.7) 8.8 % 7.70 [ -0.77, 16.17 ]
Subtotal (95% CI) 403 385 81.8 % -3.11 [ -7.13, 0.92 ]
Heterogeneity: Tau2 = 22.30; Chi2 = 25.90, df = 9 (P = 0.002); I2 =65%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Initial Barthel < 10
Adelaide 2000 3 39 (19) 4 64 (18) 2.4 % -25.00 [ -52.81, 2.81 ]
Belfast 2004 8 59 (34) 11 111 (36) 1.9 % -52.00 [ -83.74, -20.26 ]
London 1999 44 56 (35) 42 76 (54) 4.1 % -20.00 [ -39.33, -0.67 ]
Newcastle 1997 11 50 (29) 12 75 (38) 2.5 % -25.00 [ -52.49, 2.49 ]
Oslo 2000 5 53 (19) 8 64 (22) 3.3 % -11.00 [ -33.58, 11.58 ]
Stockholm 1998 5 23 (7) 2 71 (16) 3.2 % -48.00 [ -71.01, -24.99 ]
Trondheim 2004 6 42.8 (50.8) 11 67.3 (58.5) 0.8 % -24.50 [ -77.86, 28.86 ]
Subtotal (95% CI) 82 90 18.2 % -28.32 [ -39.93, -16.71 ]
Heterogeneity: Tau2 = 61.28; Chi2 = 8.04, df = 6 (P = 0.24); I2 =25%
Test for overall effect: Z = 4.78 (P < 0.00001)
Total (95% CI) 485 475 100.0 % -7.33 [ -12.15, -2.50 ]
Heterogeneity: Tau2 = 50.24; Chi2 = 56.87, df = 16 (P<0.00001); I2 =72%
Test for overall effect: Z = 2.98 (P = 0.0029)
Test for subgroup differences: Chi2 = 16.17, df = 1 (P = 0.00), I2 =94%
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Analysis 8.1. Comparison 8 Early supported discharge service versus conventional care: carer subgroups,
Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 8 Early supported discharge service versus conventional care: carer subgroups
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Carer present
Adelaide 2000 9/24 11/25 4.3 % 0.76 [ 0.24, 2.39 ]
Akershus 1998 37/73 40/83 11.9 % 1.10 [ 0.59, 2.07 ]
Belfast 2004 23/38 24/38 6.1 % 0.89 [ 0.35, 2.26 ]
London 1999 77/116 66/102 15.2 % 1.08 [ 0.62, 1.88 ]
Manchester 2001 3/7 5/7 1.8 % 0.30 [ 0.03, 2.76 ]
Montreal 2000 17/58 24/56 11.1 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 11/24 15/22 5.5 % 0.39 [ 0.12, 1.32 ]
Oslo 2000 5/18 4/15 2.0 % 1.06 [ 0.23, 4.94 ]
Stockholm 1998 6/30 9/27 4.9 % 0.50 [ 0.15, 1.66 ]
Trondheim 2004 11/20 6/16 1.9 % 2.04 [ 0.53, 7.79 ]
Subtotal (95% CI) 408 391 64.9 % 0.86 [ 0.64, 1.14 ]
Total events: 199 (Treatment), 204 (Control)
Heterogeneity: Chi2 = 7.44, df = 9 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
2 No carer
Adelaide 2000 4/18 5/19 2.4 % 0.80 [ 0.18, 3.62 ]
Akershus 1998 33/51 21/44 5.1 % 2.01 [ 0.88, 4.58 ]
Belfast 2004 6/21 8/16 4.2 % 0.40 [ 0.10, 1.56 ]
London 1999 28/51 43/62 11.3 % 0.54 [ 0.25, 1.16 ]
Manchester 2001 2/5 2/4 0.9 % 0.67 [ 0.05, 9.47 ]
Newcastle 1997 11/22 13/24 4.0 % 0.85 [ 0.27, 2.70 ]
Oslo 2000 11/24 13/25 4.5 % 0.78 [ 0.25, 2.40 ]
Stockholm 1998 3/12 3/14 1.3 % 1.22 [ 0.20, 7.59 ]
Trondheim 2004 8/11 9/15 1.3 % 1.78 [ 0.33, 9.55 ]
Subtotal (95% CI) 215 223 35.1 % 0.90 [ 0.61, 1.32 ]
Total events: 106 (Treatment), 117 (Control)
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Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 7.59, df = 8 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 623 614 100.0 % 0.87 [ 0.69, 1.10 ]
Total events: 305 (Treatment), 321 (Control)
Heterogeneity: Chi2 = 15.05, df = 18 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.86), I2 =0.0%
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Analysis 8.2. Comparison 8 Early supported discharge service versus conventional care: carer subgroups,
Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 8 Early supported discharge service versus conventional care: carer subgroups
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Carer present
Adelaide 2000 24 19.5 (20.21) 25 37.4 (25.35) 6.5 % -17.90 [ -30.71, -5.09 ]
Belfast 2004 38 44.4 (25.48) 38 42.8 (45.05) 4.6 % 1.60 [ -14.86, 18.06 ]
London 1999 116 30.7 (32.26) 101 43.1 (44) 8.4 % -12.40 [ -22.80, -2.00 ]
Manchester 2001 6 25.6 (33.64) 7 56 (43.12) 0.9 % -30.40 [ -72.17, 11.37 ]
Montreal 2000 58 9.8 (5.32) 56 12 (7.07) 17.6 % -2.20 [ -4.50, 0.10 ]
Newcastle 1997 24 18.2 (22.05) 22 33.8 (36.05) 4.2 % -15.60 [ -33.06, 1.86 ]
Oslo 2000 18 19.7 (13.75) 15 23.4 (14.6) 9.0 % -3.70 [ -13.44, 6.04 ]
Stockholm 1998 30 12.6 (6.59) 27 33.5 (30.97) 7.1 % -20.90 [ -32.82, -8.98 ]
Trondheim 2004 20 22.2 (34.1) 11 28.3 (50.4) 1.4 % -6.10 [ -39.42, 27.22 ]
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 334 302 59.5 % -9.70 [ -16.06, -3.33 ]
Heterogeneity: Tau2 = 45.00; Chi2 = 20.78, df = 8 (P = 0.01); I2 =62%
Test for overall effect: Z = 2.99 (P = 0.0028)
2 No carer
Adelaide 2000 18 22.7 (21.44) 19 34.1 (22.73) 5.6 % -11.40 [ -25.63, 2.83 ]
Belfast 2004 21 37.5 (32.89) 16 65.4 (48.97) 1.9 % -27.90 [ -55.71, -0.09 ]
London 1999 49 37.9 (34.68) 62 38.4 (32.88) 6.6 % -0.50 [ -13.20, 12.20 ]
Manchester 2001 4 48.5 (42.79) 4 15 (7.87) 0.9 % 33.50 [ -9.14, 76.14 ]
Newcastle 1997 20 25.8 (27.33) 20 33.9 (35.21) 3.5 % -8.10 [ -27.63, 11.43 ]
Oslo 2000 24 31.5 (18.26) 25 40.1 (23.26) 7.3 % -8.60 [ -20.28, 3.08 ]
Stockholm 1998 12 15.9 (7.48) 14 21 (9.8) 12.4 % -5.10 [ -11.75, 1.55 ]
Trondheim 2004 11 25.9 (23.8) 15 32.9 (39.5) 2.4 % -7.00 [ -31.44, 17.44 ]
Subtotal (95% CI) 159 175 40.5 % -6.17 [ -11.00, -1.34 ]
Heterogeneity: Tau2 = 2.02; Chi2 = 7.26, df = 7 (P = 0.40); I2 =4%
Test for overall effect: Z = 2.50 (P = 0.012)
Total (95% CI) 493 477 100.0 % -7.96 [ -12.01, -3.92 ]
Heterogeneity: Tau2 = 22.90; Chi2 = 28.79, df = 16 (P = 0.03); I2 =44%
Test for overall effect: Z = 3.86 (P = 0.00011)
Test for subgroup differences: Chi2 = 0.75, df = 1 (P = 0.39), I2 =0.0%
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Analysis 9.1. Comparison 9 Early supported discharge service versus conventional care: ESD service
subgroups: service base, Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 9 Early supported discharge service versus conventional care: ESD service subgroups: service base
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Community in-reach
Belfast 2004 29/59 32/54 8.1 % 0.66 [ 0.32, 1.40 ]
London 1999 105/167 109/164 19.4 % 0.85 [ 0.54, 1.34 ]
Manchester 2001 5/12 7/11 2.0 % 0.41 [ 0.08, 2.19 ]
Montreal 2000 17/58 24/56 8.2 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 22/46 28/46 6.9 % 0.59 [ 0.26, 1.35 ]
Oslo 2000 16/42 17/40 5.1 % 0.83 [ 0.34, 2.01 ]
Subtotal (95% CI) 384 371 49.7 % 0.72 [ 0.53, 0.96 ]
Total events: 194 (Treatment), 217 (Control)
Heterogeneity: Chi2 = 1.81, df = 5 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 2.22 (P = 0.027)
2 Hospital out-reach
Adelaide 2000 13/42 16/44 5.1 % 0.78 [ 0.32, 1.92 ]
Copenhagen 2009 17/50 25/50 7.8 % 0.52 [ 0.23, 1.15 ]
Glostrup 2006 18/103 17/95 6.9 % 0.97 [ 0.47, 2.02 ]
Stockholm 1998 9/42 12/41 4.5 % 0.66 [ 0.24, 1.79 ]
Trondheim 2000 64/160 81/160 23.1 % 0.65 [ 0.42, 1.01 ]
Trondheim 2004 19/31 15/31 2.8 % 1.69 [ 0.62, 4.63 ]
Subtotal (95% CI) 428 421 50.3 % 0.74 [ 0.56, 1.00 ]
Total events: 140 (Treatment), 166 (Control)
Heterogeneity: Chi2 = 4.27, df = 5 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.047)
Total (95% CI) 812 792 100.0 % 0.73 [ 0.59, 0.90 ]
Total events: 334 (Treatment), 383 (Control)
Heterogeneity: Chi2 = 6.11, df = 11 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 2.97 (P = 0.0029)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.85), I2 =0.0%
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Analysis 9.2. Comparison 9 Early supported discharge service versus conventional care: ESD service
subgroups: service base, Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 9 Early supported discharge service versus conventional care: ESD service subgroups: service base
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Community in-reach
Belfast 2004 59 41.9 (28.25) 54 49.5 (46.95) 5.6 % -7.60 [ -22.05, 6.85 ]
London 1999 165 32.8 (33.05) 163 41.3 (40.09) 10.7 % -8.50 [ -16.46, -0.54 ]
Manchester 2001 10 39.8 (35.78) 11 46.1 (41.17) 1.4 % -6.30 [ -39.22, 26.62 ]
Montreal 2000 58 9.8 (5.3) 56 12 (7.07) 16.8 % -2.20 [ -4.50, 0.10 ]
Newcastle 1997 44 21.6 (24.59) 42 33.8 (35.22) 6.5 % -12.20 [ -25.09, 0.69 ]
Oslo 2000 42 26.4 (17.33) 40 33.8 (21.83) 10.1 % -7.40 [ -15.96, 1.16 ]
Subtotal (95% CI) 378 366 51.1 % -4.34 [ -7.34, -1.34 ]
Heterogeneity: Tau2 = 2.15; Chi2 = 5.60, df = 5 (P = 0.35); I2 =11%
Test for overall effect: Z = 2.84 (P = 0.0046)
2 Hospital out-reach
Adelaide 2000 42 20.9 (22.55) 44 36 (24.04) 8.8 % -15.10 [ -24.95, -5.25 ]
Copenhagen 2009 50 16.5 (10) 50 15 (16) 13.8 % 1.50 [ -3.73, 6.73 ]
Stockholm 1998 42 13.6 (6.93) 41 29.2 (26.28) 10.3 % -15.60 [ -23.91, -7.29 ]
Trondheim 2000 160 18.6 (30) 160 31.1 (30) 12.2 % -12.50 [ -19.07, -5.93 ]
Trondheim 2004 31 23.5 (30.5) 31 30.5 (44.8) 3.7 % -7.00 [ -26.08, 12.08 ]
Subtotal (95% CI) 325 326 48.9 % -9.62 [ -17.88, -1.36 ]
Heterogeneity: Tau2 = 65.10; Chi2 = 19.52, df = 4 (P = 0.00062); I2 =80%
Test for overall effect: Z = 2.28 (P = 0.022)
Total (95% CI) 703 692 100.0 % -7.86 [ -11.99, -3.73 ]
Heterogeneity: Tau2 = 25.07; Chi2 = 28.92, df = 10 (P = 0.001); I2 =65%
Test for overall effect: Z = 3.73 (P = 0.00019)
Test for subgroup differences: Chi2 = 1.39, df = 1 (P = 0.24), I2 =28%
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Analysis 10.1. Comparison 10 Early supported discharge service versus conventional care: ESD service
subgroups: MDT co-ordination, Outcome 1 Death.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 10 Early supported discharge service versus conventional care: ESD service subgroups: MDT co-ordination
Outcome: 1 Death
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 MDT co-ordination
Adelaide 2000 2/42 0/44 0.6 % 5.49 [ 0.26, 117.88 ]
Belfast 2004 1/59 3/54 3.8 % 0.29 [ 0.03, 2.91 ]
Copenhagen 2009 0/50 3/50 4.3 % 0.13 [ 0.01, 2.67 ]
Glostrup 2006 3/103 3/95 3.8 % 0.92 [ 0.18, 4.67 ]
London 1999 26/167 34/164 36.2 % 0.71 [ 0.40, 1.24 ]
Manchester 2001 1/12 2/11 2.4 % 0.41 [ 0.03, 5.28 ]
Montreal 2000 2/58 0/56 0.6 % 5.00 [ 0.23, 106.50 ]
Newcastle 1997 2/46 4/46 4.8 % 0.48 [ 0.08, 2.74 ]
Oslo 2000 2/42 4/40 4.9 % 0.45 [ 0.08, 2.61 ]
Stockholm 1998 1/42 3/41 3.7 % 0.31 [ 0.03, 3.10 ]
Trondheim 2000 13/160 15/160 17.2 % 0.85 [ 0.39, 1.86 ]
Trondheim 2004 8/31 5/31 4.6 % 1.81 [ 0.52, 6.31 ]
Subtotal (95% CI) 812 792 87.0 % 0.77 [ 0.54, 1.09 ]
Total events: 61 (Treatment), 76 (Control)
Heterogeneity: Chi2 = 8.49, df = 11 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.47 (P = 0.14)
2 No MDT
Akershus 1998 20/124 12/127 12.4 % 1.84 [ 0.86, 3.95 ]
Bangkok 2002 1/52 0/50 0.6 % 2.94 [ 0.12, 73.93 ]
Subtotal (95% CI) 176 177 13.0 % 1.90 [ 0.90, 3.98 ]
Total events: 21 (Treatment), 12 (Control)
Heterogeneity: Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.091)
Total (95% CI) 988 969 100.0 % 0.91 [ 0.67, 1.25 ]
Total events: 82 (Treatment), 88 (Control)
Heterogeneity: Chi2 = 13.15, df = 13 (P = 0.44); I2 =1%
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Chi2 = 4.66, df = 1 (P = 0.03), I2 =79%
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Analysis 10.2. Comparison 10 Early supported discharge service versus conventional care: ESD service
subgroups: MDT co-ordination, Outcome 2 Death or requiring institutional care.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 10 Early supported discharge service versus conventional care: ESD service subgroups: MDT co-ordination
Outcome: 2 Death or requiring institutional care
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 MDT co-ordination
Copenhagen 2009 8/50 12/50 7.0 % 0.60 [ 0.22, 1.63 ]
Glostrup 2006 7/103 3/95 2.0 % 2.24 [ 0.56, 8.91 ]
London 1999 41/167 55/164 28.9 % 0.64 [ 0.40, 1.04 ]
Manchester 2001 2/12 3/11 1.8 % 0.53 [ 0.07, 4.01 ]
Montreal 2000 2/58 4/56 2.7 % 0.46 [ 0.08, 2.64 ]
Newcastle 1997 4/46 9/46 5.7 % 0.39 [ 0.11, 1.38 ]
Oslo 2000 10/42 15/40 8.1 % 0.52 [ 0.20, 1.35 ]
Stockholm 1998 1/42 3/41 2.0 % 0.31 [ 0.03, 3.10 ]
Trondheim 2000 34/160 43/160 23.4 % 0.73 [ 0.44, 1.23 ]
Trondheim 2004 11/31 9/31 4.0 % 1.34 [ 0.46, 3.92 ]
Subtotal (95% CI) 711 694 85.6 % 0.69 [ 0.53, 0.91 ]
Total events: 120 (Treatment), 156 (Control)
Heterogeneity: Chi2 = 6.32, df = 9 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 2.64 (P = 0.0082)
2 No MDT
Akershus 1998 33/124 28/127 14.0 % 1.28 [ 0.72, 2.29 ]
Bangkok 2002 1/52 0/50 0.3 % 2.94 [ 0.12, 73.93 ]
Subtotal (95% CI) 176 177 14.4 % 1.32 [ 0.75, 2.33 ]
Total events: 34 (Treatment), 28 (Control)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Total (95% CI) 887 871 100.0 % 0.78 [ 0.61, 1.00 ]
Total events: 154 (Treatment), 184 (Control)
Heterogeneity: Chi2 = 10.57, df = 11 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 1.97 (P = 0.049)
Test for subgroup differences: Chi2 = 4.06, df = 1 (P = 0.04), I2 =75%
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Analysis 10.3. Comparison 10 Early supported discharge service versus conventional care: ESD service
subgroups: MDT co-ordination, Outcome 3 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 10 Early supported discharge service versus conventional care: ESD service subgroups: MDT co-ordination
Outcome: 3 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 MDT co-ordination
Adelaide 2000 13/42 16/44 4.4 % 0.78 [ 0.32, 1.92 ]
Belfast 2004 29/59 32/54 6.9 % 0.66 [ 0.32, 1.40 ]
Copenhagen 2009 17/50 25/50 6.7 % 0.52 [ 0.23, 1.15 ]
Glostrup 2006 18/103 17/95 5.9 % 0.97 [ 0.47, 2.02 ]
London 1999 105/167 109/164 16.6 % 0.85 [ 0.54, 1.34 ]
Manchester 2001 5/12 7/11 1.7 % 0.41 [ 0.08, 2.19 ]
Montreal 2000 17/58 24/56 7.0 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 22/46 28/46 5.9 % 0.59 [ 0.26, 1.35 ]
Oslo 2000 16/42 17/40 4.4 % 0.83 [ 0.34, 2.01 ]
Stockholm 1998 9/42 12/41 3.9 % 0.66 [ 0.24, 1.79 ]
Trondheim 2000 64/160 81/160 19.7 % 0.65 [ 0.42, 1.01 ]
Trondheim 2004 19/31 15/31 2.4 % 1.69 [ 0.62, 4.63 ]
Subtotal (95% CI) 812 792 85.6 % 0.73 [ 0.59, 0.90 ]
Total events: 334 (Treatment), 383 (Control)
Heterogeneity: Chi2 = 6.11, df = 11 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 2.97 (P = 0.0029)
2 No MDT
Akershus 1998 70/124 61/127 10.7 % 1.40 [ 0.85, 2.31 ]
Bangkok 2002 9/52 11/50 3.8 % 0.74 [ 0.28, 1.98 ]
Subtotal (95% CI) 176 177 14.4 % 1.23 [ 0.79, 1.91 ]
Total events: 79 (Treatment), 72 (Control)
Heterogeneity: Chi2 = 1.29, df = 1 (P = 0.26); I2 =22%
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI) 988 969 100.0 % 0.80 [ 0.67, 0.97 ]
Total events: 413 (Treatment), 455 (Control)
Heterogeneity: Chi2 = 11.77, df = 13 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Chi2 = 4.38, df = 1 (P = 0.04), I2 =77%
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Analysis 10.4. Comparison 10 Early supported discharge service versus conventional care: ESD service
subgroups: MDT co-ordination, Outcome 4 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 10 Early supported discharge service versus conventional care: ESD service subgroups: MDT co-ordination
Outcome: 4 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 MDT co-ordination
Adelaide 2000 42 20.9 (20.56) 44 36 (24.04) 6.2 % -15.10 [ -24.54, -5.66 ]
Belfast 2004 59 41.9 (28.25) 54 49.5 (46.95) 3.3 % -7.60 [ -22.05, 6.85 ]
Copenhagen 2009 50 16.5 (10) 50 15 (16) 11.2 % 1.50 [ -3.73, 6.73 ]
Glostrup 2006 103 35.2 (30) 95 39.8 (30) 7.2 % -4.60 [ -12.96, 3.76 ]
London 1999 165 32.8 (33.05) 163 41.3 (40.09) 7.6 % -8.50 [ -16.46, -0.54 ]
Manchester 2001 10 39.8 (35.78) 11 46.09 (41.17) 0.7 % -6.29 [ -39.21, 26.63 ]
Montreal 2000 58 9.8 (5.32) 56 12 (7.07) 15.8 % -2.20 [ -4.50, 0.10 ]
Newcastle 1997 44 21.6 (24.59) 42 33.8 (21.83) 5.9 % -12.20 [ -22.02, -2.38 ]
Oslo 2000 42 26.4 (17.33) 40 33.8 (21.83) 7.0 % -7.40 [ -15.96, 1.16 ]
Stockholm 1998 42 13.6 (6.93) 41 29.2 (26.28) 7.2 % -15.60 [ -23.91, -7.29 ]
Trondheim 2000 160 18.6 (30) 160 31.1 (30) 9.3 % -12.50 [ -19.07, -5.93 ]
Trondheim 2004 31 23.5 (30.5) 31 30.5 (44.8) 2.1 % -7.00 [ -26.08, 12.08 ]
Subtotal (95% CI) 806 787 83.4 % -7.62 [ -11.39, -3.86 ]
Heterogeneity: Tau2 = 22.62; Chi2 = 30.30, df = 11 (P = 0.001); I2 =64%
Test for overall effect: Z = 3.97 (P = 0.000072)
2 No MDT
Bangkok 2002 52 3 (3) 50 10 (5) 16.6 % -7.00 [ -8.61, -5.39 ]
Subtotal (95% CI) 52 50 16.6 % -7.00 [ -8.61, -5.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.53 (P < 0.00001)
Total (95% CI) 858 837 100.0 % -7.21 [ -10.12, -4.30 ]
Heterogeneity: Tau2 = 12.60; Chi2 = 34.42, df = 12 (P = 0.00058); I2 =65%
Test for overall effect: Z = 4.85 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.77), I2 =0.0%
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Analysis 11.1. Comparison 11 Early supported discharge service versus conventional care: conventional
service subgroups, Outcome 1 Death or dependency.
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 11 Early supported discharge service versus conventional care: conventional service subgroups
Outcome: 1 Death or dependency
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Stroke unit
Adelaide 2000 13/42 16/44 4.4 % 0.78 [ 0.32, 1.92 ]
Akershus 1998 70/124 61/127 10.7 % 1.40 [ 0.85, 2.31 ]
Belfast 2004 19/45 23/41 5.7 % 0.57 [ 0.24, 1.34 ]
Copenhagen 2009 17/50 25/50 6.7 % 0.52 [ 0.23, 1.15 ]
London 1999 12/21 15/24 2.4 % 0.80 [ 0.24, 2.64 ]
Oslo 2000 16/42 17/40 4.4 % 0.83 [ 0.34, 2.01 ]
Stockholm 1998 9/42 12/41 3.9 % 0.66 [ 0.24, 1.79 ]
Trondheim 2000 64/160 81/160 19.8 % 0.65 [ 0.42, 1.01 ]
Trondheim 2004 19/31 15/31 2.4 % 1.69 [ 0.62, 4.63 ]
Subtotal (95% CI) 557 558 60.3 % 0.83 [ 0.66, 1.06 ]
Total events: 239 (Treatment), 265 (Control)
Heterogeneity: Chi2 = 9.65, df = 8 (P = 0.29); I2 =17%
Test for overall effect: Z = 1.52 (P = 0.13)
2 Other wards
Bangkok 2002 9/52 11/50 3.8 % 0.74 [ 0.28, 1.98 ]
Belfast 2004 10/14 9/13 1.1 % 1.11 [ 0.21, 5.80 ]
Glostrup 2006 18/103 17/95 5.9 % 0.97 [ 0.47, 2.02 ]
London 1999 93/146 94/140 14.2 % 0.86 [ 0.53, 1.40 ]
Manchester 2001 5/12 7/11 1.7 % 0.41 [ 0.08, 2.19 ]
Montreal 2000 17/58 24/56 7.0 % 0.55 [ 0.25, 1.20 ]
Newcastle 1997 22/46 28/46 5.9 % 0.59 [ 0.26, 1.35 ]
Subtotal (95% CI) 431 411 39.7 % 0.76 [ 0.56, 1.02 ]
Total events: 174 (Treatment), 190 (Control)
Heterogeneity: Chi2 = 2.42, df = 6 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.070)
Total (95% CI) 988 969 100.0 % 0.80 [ 0.67, 0.97 ]
Total events: 413 (Treatment), 455 (Control)
Heterogeneity: Chi2 = 12.28, df = 15 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 2.31 (P = 0.021)
Test for subgroup differences: Chi2 = 0.23, df = 1 (P = 0.63), I2 =0.0%
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Analysis 11.2. Comparison 11 Early supported discharge service versus conventional care: conventional
service subgroups, Outcome 2 Length of stay (days).
Review: Services for reducing duration of hospital care for acute stroke patients
Comparison: 11 Early supported discharge service versus conventional care: conventional service subgroups
Outcome: 2 Length of stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke unit
Adelaide 2000 42 20.9 (20.56) 44 36 (24.04) 7.0 % -15.10 [ -24.54, -5.66 ]
Belfast 2004 45 42.1 (28.74) 41 39.9 (36.42) 4.2 % 2.20 [ -11.76, 16.16 ]
Copenhagen 2009 50 16.5 (10) 50 15 (16) 11.4 % 1.50 [ -3.73, 6.73 ]
London 1999 19 49.8 (48.89) 23 29 (17.98) 1.8 % 20.80 [ -2.38, 43.98 ]
Manchester 2001 10 39.8 (35.78) 11 46.1 (41.17) 1.0 % -6.30 [ -39.22, 26.62 ]
Oslo 2000 42 26.4 (17.33) 40 33.8 (21.83) 7.8 % -7.40 [ -15.96, 1.16 ]
Stockholm 1998 42 13.6 (6.93) 41 29.2 (26.28) 8.0 % -15.60 [ -23.91, -7.29 ]
Trondheim 2000 160 18.6 (30) 160 31.1 (30) 9.8 % -12.50 [ -19.07, -5.93 ]
Trondheim 2004 31 23.5 (30.5) 31 30.5 (44.8) 2.6 % -7.00 [ -26.08, 12.08 ]
Subtotal (95% CI) 441 441 53.8 % -6.37 [ -12.76, 0.02 ]
Heterogeneity: Tau2 = 56.04; Chi2 = 26.85, df = 8 (P = 0.00075); I2 =70%
Test for overall effect: Z = 1.96 (P = 0.051)
2 Other wards
Bangkok 2002 52 3 (3) 50 10 (5) 15.3 % -7.00 [ -8.61, -5.39 ]
Belfast 2004 14 41.3 (27.66) 13 80 (63.15) 0.8 % -38.70 [ -75.96, -1.44 ]
London 1999 146 30.6 (29.93) 139 43.4 (42.48) 7.8 % -12.80 [ -21.37, -4.23 ]
Manchester 2001 10 39.8 (35.78) 11 46.1 (41.17) 1.0 % -6.30 [ -39.22, 26.62 ]
Montreal 2000 58 9.8 (5.32) 56 12 (7.07) 14.7 % -2.20 [ -4.50, 0.10 ]
Newcastle 1997 44 21.6 (24.59) 42 33.8 (21.83) 6.7 % -12.20 [ -22.02, -2.38 ]
Subtotal (95% CI) 324 311 46.2 % -7.25 [ -11.47, -3.03 ]
Heterogeneity: Tau2 = 12.21; Chi2 = 18.71, df = 5 (P = 0.002); I2 =73%
Test for overall effect: Z = 3.37 (P = 0.00075)
Total (95% CI) 765 752 100.0 % -7.28 [ -10.64, -3.93 ]
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 18.50; Chi2 = 45.72, df = 14 (P = 0.00003); I2 =69%
Test for overall effect: Z = 4.25 (P = 0.000021)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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Table 1. Characteristics and staffing of ESD trials
Trial Setting Key fea-
tures
Control
service
base
ESD staffing (whole time equivalents for caseload of 100 patients/year; median and
range)
Medical Nursing Physio OT SALT Assis-
tant
Other Total
Adelaide
2000
Urban PHMR
Goals
docu-
mented
Rehabil-
ita-
tion unit
(stroke
and neu-
rologi-
cal)
0.06 0.06 0.7 1.6 0.25 0.4 Social
work
2.6
Aveiro Mixed Tailored Mixture
(stroke
unit,
case
man-
agers
in com-
munity-
based
team)
0.8 0 1.0 1.5 0 0 Psychol-
ogy
3.2
Belfast
2004
Mixed PHMR Mixture
(medi-
cal, geri-
atric,
stroke
0.1 0 1.5 1.0 0.5 1.5 Secre-
tary
Social
work
4.6
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Table 1. Characteristics and staffing of ESD trials (Continued)
unit)
Copen-
hagen
2009
Urban Tailored Stroke
unit
Glostrup
2006
Mixed Tailored Neurol-
ogy,
geri-
atrics
0 0 2.0 2.0 0 0 0 4.0
London
1999
Urban Equip-
ment
store
Mixture
(medi-
cal,
stroke
unit)
0.1 0 1 1 0.5 0.5 - 3.1
Manch-
ester
2001
Urban Mixture
(medi-
cal,
stroke
team or
unit)
nd nd nd nd nd nd - nd
Mon-
treal
2000
Urban Mixture
(med-
ical neu-
rology)
0 0.4 1.0 0.7 0.4 - Dieti-
tian
2.7
Newcas-
tle
1997
Urban Envt
visit
Key
worker
7-day
input
PHMR
Mixture
(medi-
cal, geri-
atric)
0 0 0.8 1.0 0.3 0.2 Secre-
tary
Social
work
Carers
2.8
Stock-
holm
1998
Urban Case
manager
Patient
diary
Stroke
unit
0.03 0 1.0 1.0 0.5 - - 2.6
Oslo
2000
Urban Key
worker
Com-
munity
services
Stroke
unit
nd nd nd nd nd nd - nd
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Table 1. Characteristics and staffing of ESD trials (Continued)
Trond-
heim
2000
Urban Key
worker
Team
Com-
munity
services
Stroke
unit
0.12 1.2 1.2 1.2 0 - - 3.7
Trond-
heim
2004
Rural Stroke
unit
0.12 1.2 1.2 1.2 0 - - 3.7
West
Den-
mark
Mixed Tailored Neu-
roreha-
bilita-
tion cen-
tres (3)
? 0 ? ? 0 0 0 ?
9 urban
4 mixed
1 rural
6 stroke
unit
6 mixed
service
2 neu-
roreha-
bilita-
tion
unit
0.08
(0 to 0.
12)
0
(0 to 1.
2)
1.1
(0.7 to
2)
1.0
(0.7 to
2)
0.1 (0 to
0.5)
0.2
(0 to 1.
5)
- 3.0
(2.6 to
4.6)
MDT mtg: multidisciplinary team meeting
N: number of participants
nd: no comparable data
OT: occupational therapy
PDHV: pre-discharge home visit
PHMR: patient held medical record
physio: physiotherapy
PNH: private nursing home
SALT: speech and language therapy
Table 2. Plan and timing of primary analyses
Trial Death Institutional care Dependency Defined dependent Length of stay
Adelaide 2000 6 months 6 months 6 months Barthel index < 95/100 Initial hospital discharge
Akershus 1998 7 months 7 months 7 months Barthel index < 95/100 Not used - only available for
acute hospital
Bangkok 2002 6 months 6 months 6 months Barthel index < 95/100 Initial hospital discharge
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Table 2. Plan and timing of primary analyses (Continued)
Belfast 2004 12 months 12 months 12 months Barthel index < 19/20 Initial hospital discharge
Copenhagen 2009 5 months 5 months 3 months Rankin score 3 to 5 Initial hospital stay
Glostrup 2006 12 months 12 months 6 months Barthel index - significant re-
duction
Initial hospital discharge
London 1999 12 months 12 months 12 months Barthel index < 19/20 Initial hospital discharge
Manchester 2001 12 months 12 months 12 months Barthel index < 19/20 Initial hospital stay (acute
and rehabilitation wards)
Montreal 2000 3 months 3 months 3 months Barthel index < 95/100 Initial hospital stay
Newcastle 1997 3 month 3 month 3 month Rankin score 3 to 5 Initial hospital stay
Oslo 2000 6 month 6 month 6 month Rankin score 3 to 5 Initial hospital stay
Stockholm 1998 6 month 6 month 6 month Barthel index 95/100 Initial hospital stay
Trondheim 2000 6 months 6 months 6 months Barthel index 95/100 Initial hospital stay
Trondheim 2004 12 months 12 months 12 months Rankin score 3 to 5 Initial hospital stay (acute
and rehabilitation wards)
Table 3. Plan of secondary analyses: patient outcomes
Trial Timing of
outcome
ADL score Extended
ADL score
Subjective
health
Mood Service satis-
faction
Hospital
readmission
Adelaide 2000 6 months Barthel index
(median,
IQR)
Adelaide Ac-
tivities Profile
SF-36 (Gen-
eral health
perceptions)
SF-36 (mental
health)
Satis-
fied with reha-
bilitation pro-
gramme
6 months
Akershus
1998
7 month Barthel index
(median, im-
puted SD)
- SF-36 (general
health percep-
tions)
SF-36 (mental
health)
- -
Bangkok 2002 - - - - - - -
Belfast 2004 12 months Barthel index Notting-
ham extended
ADL
SF-36 (general
health percep-
tions)
SF-36 (mental
health)
Satisfied with
outpatient re-
habilitation
6 month
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Table 3. Plan of secondary analyses: patient outcomes (Continued)
Copenhagen
2009
3 months Barthel Index
(median, im-
puted SD)
- EQ-5D - 5 months
Glostrup
2006
6 months Barthel index Frenchay ac-
tivities index
SF-36 GDS - 12 month
London 1999 12 months Barthel index Rivermead
ADL score
Nottingham
health pro-
file (score re-
versed)
Number
abnormal on
hospital anx-
iety and de-
pression scale
Satisfied with
care in general
12 month
Manchester
2001
12 months Barthel index Notting-
ham extended
ADL score
Euroquol scale
(0 to 100)
Hospital anx-
iety and de-
pression scale
(depres-
sion subscore,
score reversed)
- -
Montreal
2000
3 month Barthel index Instrumental
ADL (OARS)
scale
SF-36 (general
health percep-
tions)
SF-36 (mental
health)
- -
Newcastle
1997
3 month - Notting-
ham extended
ADL
score (median,
IQR)
Dartmouth
COOP chart
over-
all health sec-
tion (median,
IQR; scale re-
versed)
Dartmouth
COOP chart
feelings sec-
tion (median,
IQR; scale re-
versed)
- 3 month
Oslo 2000 6 month - Notting-
ham extended
ADL
score (median,
IQR)
General
Health Ques-
tionnaire (re-
versed score)
MADRS score Satisfied with
care in general
-
Stockholm
1998
8 months - Frenchay Ac-
tivi-
ties index (me-
dian, IQR)
Sickness
impact profile
score (median,
IQR)
- Satisfied with
care received
6 months
Trondheim
2000
12 months - Frenchay so-
cial activity in-
dex
Nottingham
Health Pro-
file (average of
sum 1 and 2)
MADRS - -
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Table 3. Plan of secondary analyses: patient outcomes (Continued)
Trondheim
2004
12 months Barthel Index - Nottingham
health profile
- - -
ADL: activities of daily living
COOP: Care Cooperative Information Project
GDS: Geriatric Depression Scale
IQR: interquartile range
MADRS: Montgomery-Åsberg Depression Rating Scale
OARS: Older Americans Resources and Services scale
SD: standard deviation
SF: short form
Table 4. Plan of secondary analyses: carer outcomes
Trial Timing of outcome Subjective health Mood Service satisfaction
Adelaide 2000 6 months SF-36 general health per-
ceptions
SF-36 mental health Satisfied with rehabilitation
programme
Akershus 1998 - - - -
Bangkok 2002 - - - -
Belfast 2004 6 months Caregiver strain index
(score reversed)
- Satisfied with outpatient
services
Copenhagen 2009 3 months Satisfied with rehabilitation
programme
Glostrup 2006 - - - -
London 1999 12 months Caregiver strain index
(score reversed)
- Satisfied with care in gen-
eral
Manchester 2001 12 month - Hospital anxiety and de-
pression scale (depression
subscore, score reversed)
-
Montreal 2000 3 months Caregiver Burden Index - -
Newcastle 1997 3 months General health question-
naire (median, range; score
reversed)
- -
Oslo 2000 6 months General health question-
naire (score reversed)
- Satisfied with care in gen-
eral
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Table 4. Plan of secondary analyses: carer outcomes (Continued)
Stockholm 1998 - - - -
Trondheim 2000 12 months Caregiver Burden score - -
Trondheim 2004 12 months Caregiver strain index
(score reversed)
- -
Table 5. Patterns of discharge from hospital in ESD and control groups
Time from randomisa-
tion
Number (%) discharged Risk difference (95% CI) Significance
ESD service
(364 patients)
Control
(354 patients)
2 weeks 116 (32%) 77 (22%) 11 (-3, 24) 0.13
4 weeks 236 (65%) 179 (50%) 19 (4, 35) 0.01
6 weeks 277 (76%) 249 (70 %) 8 (1, 15) 0.02
8 weeks 303 (83%) 275 (78%) 8 (3, 13) 0.003
3 months 345 (95%) 324 (92%) 2 (-1, 6) 0.21
6 months 363 (100%) 353 (100%) 0 (-2, 1) 0.71
Data are presented from six trials (Adelaide 2000, Belfast 2004, London 1999, Manchester 2001, Oslo 2000, Stockholm 1998) that
could provide relevant data on 718 participants. Discharges include deaths and do not include readmissions. The risk difference (95%
confidence interval) is calculated taking into account variation between trials
Table 6. Service costs of individual trials
Trial Items costed ESD cost / patient Control cost / pt Percent difference
Adelaide 2000 Cost minimisation. Direct
and indirect
$8040 Aus $10054 Aus - 20%
Glostrup 2006 Direct costs EURO7674 EURO6660 +15%
London 1999 Direct and indirect to 12
months
£6800 £7432 - 9%
Montreal 2000 Direct and indirect to 3
months
$7784 Canadian $11,065 Canadian -30%
Newcastle 1997 Direct and indirect £7155 £7480 - 4%
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Table 6. Service costs of individual trials (Continued)
Stockholm 1998 Hospital, community, pri-
vate costs
2806 SEK 3475 SEK - 19%
Trondheim 2000 Direct costs to 12 months EURO5,113 EURO6,665 - 23%
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (Ovid) search strategy
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial hemorrhages/ or stroke/ or stroke,
lacunar/ or exp brain infarction/ or exp vertebral artery dissection/
2. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$).tw.
3. ((brain$ or cerebr$ or cerebell$ or vertebrobasilar or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
MCA or anterior circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraventricular or infratentorial or supratentorial
or basal gangli$) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).tw.
5. 1 or 2 or 3 or 4
6. Patient Discharge/
7. Progressive Patient Care/
8. home care services/ or home care services, hospital-based/ or home nursing/
9. (early supported discharge or ESD).tw.
10. ((early or earlier or prompt or accelerate$ or acute or subacute or supported) adj5 discharg$).tw.
11. (reduce$ adj5 (duration or length) adj5 (stay or hospital)).tw.
12. (reduce$ adj5 (hospital or inpatient or in-patient) adj5 (stay or care)).tw.
13. short-term ward.tw.
14. ((organi?ed or multidisciplinary) adj5 discharge adj5 team$).tw.
15. ((early or earlier or prompt or accelerate$ or supported) adj5 return$ adj2 home$).tw.
16. (hospital$ adj3 home$).tw.
17. hospital rehabilitation unit$.tw.
18. (rehabilitation adj3 home$).tw.
19. (intensive adj2 home adj5 (rehabilitation or support$)).tw.
20. (mobile adj2 team$).tw.
21. organi?ed home care.tw.
22. ((extended stroke unit adj3 (service$ or care)) or ESUS).tw.
23. ((post-discharge or home rehabilitation) adj5 (support$ or care)).tw.
24. ((early or earlier or acute or subacute or post-discharge) adj5 (community or domiciliary or primary care or home or home-based)
adj5 (rehabilitation or support$ or care)).tw.
25. or/6-24
26. 5 and 25
27. Randomized Controlled Trials as Topic/
28. random allocation/
29. Controlled Clinical Trials as Topic/
30. control groups/
92Services for reducing duration of hospital care for acute stroke patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
31. clinical trials as topic/
32. double-blind method/
33. single-blind method/
34. Research Design/
35. Program Evaluation/
36. randomised controlled trial.pt.
37. controlled clinical trial.pt.
38. clinical trial.pt.
39. random$.tw.
40. (controlled adj5 (trial$ or stud$)).tw.
41. (clinical$ adj5 trial$).tw.
42. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
43. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
44. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
45. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
46. (assign$ or allocat$).tw.
47. controls.tw.
48. trial.ti.
49. or/27-48
50. 26 and 49
51. exp animals/ not humans.sh.
52. 50 not 51
Appendix 2. EMBASE search strategy
EMBASE (Ovid) search strategy
1. cerebrovascular disease/ or basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarction/ or
exp brain ischemia/ or exp carotid artery disease/ or cerebral artery disease/ or cerebrovascular accident/ or exp intracranial aneurysm/
or exp occlusive cerebrovascular disease/ or stroke/
2. stroke patient/ or stroke unit/
3. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$).tw.
4. ((brain$ or cerebr$ or cerebell$ or vertebrobasilar or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
MCA or anterior circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$)).tw.
5. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraventricular or infratentorial or supratentorial
or basal gangli$) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).tw.
6. 1 or 2 or 3 or 4 or 5
7. hospital discharge/
8. early supported discharge/
9. progressive patient care/
10. home care/ or home physiotherapy/ or home rehabilitation/
11. home environment/
12. community based rehabilitation/
13. (early supported discharge or ESD).tw.
14. ((early or earlier or prompt or accelerate$ or acute or subacute or supported) adj5 discharg$).tw.
15. (reduce$ adj5 (duration or length) adj5 (stay or hospital)).tw.
16. (reduce$ adj5 (hospital or inpatient or in-patient) adj5 (stay or care)).tw.
17. short-term ward.tw.
18. ((organi?ed or multidisciplinary) adj5 discharge adj5 team$).tw.
19. ((early or earlier or prompt or accelerate$ or supported) adj5 return$ adj2 home$).tw.
20. (hospital$ adj3 home$).tw.
21. hospital rehabilitation unit$.tw.
22. (rehabilitation adj3 home$).tw.
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23. (intensive adj2 home adj5 (rehabilitation or support$)).tw.
24. (mobile adj2 team$).tw.
25. organi?ed home care.tw.
26. ((extended stroke unit adj3 (service$ or care)) or ESUS).tw.
27. ((post-discharge or home rehabilitation) adj5 (support$ or care)).tw.
28. ((early or earlier or acute or subacute or post-discharge) adj5 (community or domiciliary or primary care or home or home-based)
adj5 (rehabilitation or support$ or care)).tw.
29. or/7-28
30. Randomized Controlled Trial/
31. Randomization/
32. Controlled Study/
33. control group/
34. clinical trial/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical trial/ or controlled clinical
trial/
35. Double Blind Procedure/
36. Single Blind Procedure/ or triple blind procedure/
37. Parallel Design/
38. random$.tw.
39. (controlled adj5 (trial$ or stud$)).tw.
40. (clinical$ adj5 trial$).tw.
41. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
42. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
43. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
44. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
45. (assign$ or alternate or allocat$).tw.
46. controls.tw.
47. trial.ti.
48. or/30-47
49. 6 and 29 and 48
Appendix 3. CINAHL search strategy
CINAHL (EBSCO) search strategy
S49 .S33 and S48
S48 .S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or S42 or S43 or S44 or S45 or S46 or S47
S47 .TI trial
S46 .TI controls OR AB controls
S45 .TI ( assign* or allocat* ) OR AB ( assign* or allocat* )
S44 .TI ( (singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*) ) OR AB ( (singl* or doubl* or tripl* or trebl*) N5 (blind* or
mask*) )
S43 .TI ( (control or experiment* or conservative)N5 (treatment or therapy or procedure ormanage*) )ORAB ( (control or experiment*
or conservative) N5 (treatment or therapy or procedure or manage*) )
S42 .TI ( quasi-random* or quasi random* or pseudo-random* or pseudo random* ) OR AB ( quasi-random* or quasi random* or
pseudo-random* or pseudo random* )
S41 .TI ( (control or treatment or experiment* or intervention) N5 (group* or subject* or patient*) ) OR AB ( (control or treatment
or experiment* or intervention) N5 (group* or subject* or patient*) )
S40 .TI clinical* N5 trial* OR AB clinical* N5 trial*
S39 .TI ( controlled N5 (trial* or stud*) ) OR AB ( controlled N5 (trial* or stud*) )
S38 .TI random* OR AB random*
S37 .(MH “Program Evaluation”)
S36 .(MH “Random Assignment”)
S35 .(ZT “clinical trial”) or (ZT “randomised controlled trial”)
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S34 .(MH “Clinical Trials”) OR (MH “Double-Blind Studies”) OR (MH “Intervention Trials”) OR (MH “Randomized Controlled
Trials”) OR (MH “Single-Blind Studies”) OR (MH “Therapeutic Trials”) OR (MH “Triple-Blind Studies”)
S33 .S11 and S32
S32 .S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29
or S30 or S31
S31 .TI ( (early or earlier or acute or subacute or post-discharge) N5 (community or domiciliary or primary care or home or home-
based) N5 (rehabilitation or support* or care) ) OR AB ( (early or earlier or acute or subacute or post-discharge) N5 (community or
domiciliary or primary care or home or home-based) N5 (rehabilitation or support* or care) )
S30 .TI ( (post-discharge or home rehabilitation) N5 (support* or care) ) ORAB ( (post-discharge or home rehabilitation) N5 (support*
or care) )
S29 .TI ESUS OR AB ESUS
S28 .TI ( extended stroke unit N3 (service* or care) ) OR AB ( extended stroke unit N3 (service* or care) )
S27 .TI organi?ed home care OR AB organi?ed home care
S26 .TI mobile N2 team* OR AB mobile N2 team*
S25 .TI ( intensive N2 home N5 (rehabilitation or support*) ) OR AB ( intensive N2 home N5 (rehabilitation or support*) )
S24 .TI rehabilitation N3 home* OR AB rehabilitation N3 home*
S23 .TI hospital rehabilitation unit* OR AB hospital rehabilitation unit*
S22 .TI hospital* N3 home* OR AB hospital* N3 home*
S21 .TI ( (early or earlier or prompt or accelerate* or supported) N5 return* N2 home* ) OR AB ( (early or earlier or prompt or
accelerate* or supported) N5 return* N2 home* )
S20 .TI ( (organi?ed or multidisciplinary) N5 discharge N5 team* ) OR AB ( (organi?ed or multidisciplinary) N5 discharge N5 team*
)
S19 .TI short-term ward OR AB short-term ward
S18 .TI ( reduce* N5 (hospital or inpatient or in-patient) N5 (stay or care) ) OR AB ( reduce* N5 (hospital or inpatient or in-patient)
N5 (stay or care) )
S17 .TI ( reduce* N5 (duration or length) N5 (stay or hospital) ) OR AB ( reduce* N5 (duration or length) N5 (stay or hospital) )
S16 .TI ( (early or earlier or prompt or accelerate* or acute or subacute or supported) N5 discharg* ) OR AB ( (early or earlier or
prompt or accelerate* or acute or subacute or supported) N5 discharg* )
S15 .TI ( early supported discharge or ESD ) OR AB ( early supported discharge or ESD )
S14 .(MH “Home Health Care”) OR (MH “Home Rehabilitation+”) OR (MH “Home Nursing, Professional”)
S13 .(MH “Progressive Patient Care”)
S12 .(MH “Patient Discharge+”) OR (MH “Early Patient Discharge”)
S11 .S1 or S2 or S3 or S4 or S7 or S10
S10 .S8 and S9
S9 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma*
or hematoma* or bleed* )
S8 .TI ( brain brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraventricular or infratentorial or
supratentorial or basal gangli* ) or AB (brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraventricular
or infratentorial or supratentorial or basal gangli* )
S7 .S5 and S6
S6 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* )
S5 .TI (brain* or cerebr* or cerebell* or vertebrobasilar or hemispher* or intracran* or intracerebral or infratentorial or supratentorial
or MCA or anterior circulation or posterior circulation or basal ganglia) or AB (brain* or cerebr* or cerebell* or vertebrobasilar or
hemispher* or intracran* or intracerebral or infratentorial or supratentorial or MCA or anterior circulation or posterior circulation or
basal ganglia )
S4 .TI (stroke or cerebrovasc* or brain vasc* or cerebral vasc* or cva* or apoplex*) or AB (stroke or cerebrovasc* or brain vasc* or
cerebral vasc* or cva* or apoplex* )
S3 .(MH “Stroke Patients”)
S2 ..(MH “Cerebrovascular Disorders”) OR (MH “Basal Ganglia Cerebrovascular Disease+”) OR (MH “Carotid Artery Diseases+”)
OR (MH “Cerebral Ischemia+”) OR (MH “Cerebral Vasospasm”) OR (MH “Intracranial Arterial Diseases+”) OR (MH “Intracranial
Embolism and Thrombosis”) OR (MH “Intracranial Hemorrhage+”) OR (MH “Stroke”) OR (MH “Vertebral Artery Dissections”)
S1 .(MH “Stroke Units”)
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WH A T ’ S N E W
Last assessed as up-to-date: 20 April 2012.
Date Event Description
30 May 2012 New search has been performed This updated review identified three new trials (360 pa-
tients) and now incorporates an individual patient data
meta-analysis of 14 trials (1957 patients). We have re-
tained themodified classification of Early Supported Dis-
charge Services (into three subgroups) to reflect the vari-
ety of trials being published
6 April 2012 New citation required but conclusions have not changed New authors.
H I S T O R Y
Protocol first published: Issue 3, 1997
Review first published: Issue 3, 1999
Date Event Description
16 November 2004 New search has been performed This review (2004) incorporates an individual patient data meta-analysis
of 11 trials. This includes new data on more than double the number of
patients included in the previous version. We have retained the modified
classification of Early Supported Discharge Services (into three subgroups)
to reflect the variety of trials being published
C O N T R I B U T I O N S O F A U T H O R S
For this version of the review, Patricia Fearon updated and carried out the literature searches, reanalyzed the data and redrafted the
manuscript. Peter Langhorne supervised the update and revised the draft manuscript. The Early Supported Discharge Trialists group
provided original data, data interpretation and redrafted the manuscript.
For the previous version of the review (ESD trialists 2005) Peter Langhorne initiated the study, drafted the original protocol, co-
ordinated the project and drafted the original manuscript. Peter Langhorne, Martin Dennis and Gillian Taylor formed the writing
committee. Gillian Taylor, Peter Langhorne and Gordon Murray conducted the original statistical analyses. The Early Supported
Discharge Trialists group provided original data, data interpretation and redrafted the manuscript.
Early SupportedDischarge Trialists group consisted of: Craig Anderson (Sydney), Erik Bautz-Holter (Oslo),MartinDennis (Secretariat)
Paola Dey (Manchester), Bent Indredavik (Trondheim), Birgitte Jepson (West Denmark), Peter Langhorne (Co-ordinator), Nancy
Mayo (Montreal), Paul Mogensen (West Denmark), GordonMurray (Stastician), Michael Power (Belfast), Helen Rodgers (Newcastle),
Ole Morten Ronning (Akershus), Anthony Rudd (London), Silvana Santana (Aviero), Nijasri Suwanwela (Bangkok), Gillian Taylor
(Statistician), Lotta Widen-Holmqvist (Stockholm) and Charles Wolfe (London). All contributed to the study design, data collection,
and analysis and revision of the manuscript.
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D E C L A R A T I O N S O F I N T E R E S T
The ESD trialists conducted the original randomised trials.
S O U R C E S O F S U P P O R T
Internal sources
• University of Glasgow, UK.
• University of Edinburgh, UK.
External sources
• Stroke Association, UK.
• Chest Heart and Stroke Scotland, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Some post-hoc analyses have been carried out. These are highlighted in the text.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Length of Stay; ∗PatientDischarge [economics]; Cost-Benefit Analysis; HomeCare Services,Hospital-Based [economics; ∗organization
& administration]; Home Nursing [economics; organization & administration]; Randomized Controlled Trials as Topic; Stroke
[economics; ∗rehabilitation]
MeSH check words
Aged; Aged, 80 and over; Humans
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